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ABSTRACT 
 
Natural polyphenols have been considered as promising anti-aging compounds not only 
for their antioxidant activity, many of them also function as signaling mediators that modulate 
cellular pathways involved in cytoprotection. Avenanthramides (Avns), a group of polyphenols 
found exclusively in oats, are natural antioxidants associated with human health promotion. In this 
study, avenanthramide A, B and C (Avn A, B and C), the three most abundant Avns in oats, were 
identified and quantified from oat phenolic-rich extracts of ten oat varieties. In addition, in vitro 
antioxidant activities of oat extracts and Avn A, B and C were evaluated. It was found that Avn C 
had the highest in vitro antioxidant activity among the three Avns. To investigate the 
cytoprotective activity of Avn C, normal human skin fibroblasts (2DD) were treated with Avn C 
followed by exposure to extracellular stress and its ability to reduce cellular damage was 
determined. Pre-treatment of cells with Avn C reduced hydrogen peroxide (H2O2)-induced 
oxidative stress significantly as demonstrated by decreased intracellular free radical levels and 
antioxidant gene transcripts. Avn C pre-treatment also resulted in decreased levels of gene 
transcripts encoding pro-inflammatory cytokines in response to H2O2 or tumor necrosis factor α 
(TNF-α) stimulation. This reduction in cytokine gene transcription occurred concomitantly with 
reduced phosphorylated nuclear factor-κB (NF-κB) p65, indicating reduced pro-inflammatory 
response. To better understand the mechanisms of actions, the impact of Avn C on cellular 
signaling pathways was investigated on Avn C-treated 2DD cells without exposure to stress. We 
found that Avn C induced heme oxygenase-1 (HO-1) expression through increased DNA-Nrf2 
binding activity. Also, it reduced basal levels of pro-inflammatory cytokines through decreased 
DNA-NF-κB binding activity. Those mechanism pathways are independent of free radical 
scavenging and strongly associated with oxidation, inflammation and the aging process. Moreover, 
anti-proliferative effect of Avn C on 2DD cells was observed via mechanisms independent of 
autophagy activation. Collectively, our findings suggest that Avn C protects normal human skin 
fibroblasts against oxidative stress and inflammatory response through Nrf2/HO-1 activation and 
NF-κB inhibition and further imply that Avn C may be a potential nutraceutical for health 
promotion and disease prevention. 
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1. INTRODUCTION 
1.1 Overview  
Oats (Avena sativa L.) have many scientifically verified health-promoting effects, making 
them one of the best grains for human consumption (Butt et al., 2008; Martínez-Villaluenga and 
Peñas, 2017). The majority of the health benefits of oats are attributed to the cholesterol-lowering 
potential of β-glucan (Othman et al., 2011); however, several phytochemicals have also been found 
and recognized for their positive impacts on human health, which include phenolic compounds 
(Peterson, 2001). Since most phenolics are found in the bran layer of oat grains, oats could be a 
significant source of dietary antioxidants as they are normally consumed as whole-grain cereal 
(Peterson, 2001; Ryan et al., 2011). Major compounds that exhibit antioxidant activity in oats are 
vitamin E (tocols), phytic acid, phenolic acids, and avenanthramides (Avns) (Collins et al., 1991; 
Peterson, 2001). Avns have received increased attention in recent years because they are a group 
of unique phenolic compounds found exclusively in oats and exhibit high antioxidant activity 
(Collins, 1989). Avns are conjugates of a phenylpropanoid (p-coumaric, ferulic, or caffeic acid) 
with anthranilic acid or 5-hydroxy anthranilic acid (Collins, 1989). The majority of Avns can be 
found in oat groats, with the highest concentration in the bran. More than 20 different forms of 
Avns have been identified and the three most abundant Avns in oats have been determined and 
named as avenanthramide A (Avn A), avenanthramide B (Avn B) and avenanthramide C (Avn C) 
(Peterson, 2001). 
Avns were identified in oat groats and hullsby Collins (Collins, 1989). Subsequently, 
Dimberg and colleagues measured their antioxidant activity by the inhibition of oxygen 
consumption in a linoleic acid system and reported that their activity was 10-30 times higher than 
those of caffeic acid, ferulic acid and vanillin isolated from oats (Dimberg et al., 1993). Since then, 
a number of studies have been focused on investigating health-promoting effect of Avns or Avn-
enriched oat extracts. It has been found that Avns showed strong antioxidant activity? both in vitro 
and in vivo with Avn C being the highest (Dimberg et al., 1993; Peterson et al., 2002; Ji et al., 
2003; Lee-Manion et al., 2009; Yang et al., 2014). Moreover, several studies have indicated that 
both oat phenolic-rich extract and pure Avns had anti-inflammatory activity by reducing the 
expression of pro-inflammatory cytokines and repressing nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB) function (Guo et al., 2008; Sur et al., 2008; Chu et al., 2013; 
Yang et al., 2014). In addition, Avn C was also reported to inhibit the proliferation of rat vascular 
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smooth muscle cells through modulation of cell cycle, indicating the potential health benefit of oat 
consumption in the prevention of coronary heart disease (Nie et al, 2006a; 2006b). Notably, the 
structures of Avns are very similar to a synthetic anti-allergic drug called Tranilast, which also has 
been found to have anti-proliferative effect on rat vascular smooth muscle cells (Tanaka et al., 
1994). Recently, the anti-proliferative effects of Avns have also been examined on several 
cancerous cell lines and found that Avn C was able to decrease the proliferative rates of colonic 
cancer cell lines, including Caco-2, HT29, LS174T, HCT116 (Guo et al., 2010) and MDA-MB-
231 breast cancer (Hastings and Kenealey, 2017).  
Most natural antioxidants found in our diet exhibit few side effects in humans due to their 
rapid metabolic rate (Chow et al., 2003; Manach et al., 2005); therefore, investigation of 
preventive effect of Avns may bring some new insights for nutraceutical development. Although 
several studies have shown that Avn C had strong antioxidant property through its free radical 
scavenging in vitro (Dimberg et al., 1993; Peterson et al., 2002; Lee-Manion et al., 2009; Yang et 
al., 2014), no study has addressed the protective effect of Avn C against cellular oxidative stress. 
Therefore, investigation of the intracellular antioxidant effect of Avn C using a human cell model 
could increase the understanding of the efficacy of Avn C. Additionally, previous studies have 
focused on the therapeutic potential of Avns in disease or mouse models (Guo et al., 2008; Sur et 
al., 2008; Chu et al., 2013; Yang et al., 2014); however, there is limited evidence on the protective 
effect of Avn C against pro-inflammatory signalling in normal human cells. Also, the mechanisms 
of health-promoting effect of Avn C are still poorly understood. More importantly, disease 
prevention is usually achieved by multiple cytoprotective effects working together such as 
antioxidant, anti-inflammatory, antigenotoxic and antiproliferation through different or 
overlapping cellular pathways, resulting in an overall promoted health and increased lifespan (De 
la Fuente and Miquel, 2009; Xia et al., 2016). Therefore, exploration of multiple health benefits 
of Avn C and mechanism investigation may provide a comprehensive understanding of its function. 
 
1.2 Hypothesis 
Based on previous observations and the polyphenolic nature of Avn C, the central 
hypothesis of this research is that Avn C not only has potential antioxidant activity, it can also 
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activate signalling cascades that regulate gene expression involved in cytoprotection and regulates 
proliferative rates of normal human cells and cancer cells.  
 
1.3 Objectives 
In addressing the hypothesis of this research, the following objectives were studied: (1) 
extract, identify and quantify Avn A, B and C from oat seeds of ten varieties; (2) evaluate 
antioxidant activities of oat phenolic-rich extracts and Avn A, B & C employing ABTS and DPPH 
free radical scavenging systems; (3) investigate the protective effects of Avn C against hydrogen 
peroxide (H2O2)-induced cellular damage including oxidative stress, DNA damage and 
inflammatory responses in normal human skin fibroblasts; (4) investigate the impact of Avn C on 
gene regulation involved in inflammation and cryoprotection; and (5) determine the impact of Avn 
C on the proliferation of human normal skin cells and cancer cells. 
  
4 
 
2. LITERATURE REVIEW 
2.1 Oats 
2.1.1 Oat grains 
Oat (Avena sativa L.) is an important cereal crop in the developing world and is known as 
common covered white oat (Butt et al., 2008). Oat is an annual crop, and is predominantly grown 
in American and European countries, mainly Russia, Canada and United States of America. 
Compared to wheat, oat requires lesser nutrients but more moisture to cultivate (Ahmad et al. 
2010). It was used mostly for animal feeding until the emerging awareness of oats as a healthy 
food for human consumption in the mid-1980s. Since then, the use of oat as animal feed has 
declined steadily and has become more popular for human nutrition (Butt et al., 2008). Because 
oats are gluten-free cereals and not suitable for bread making, they are often served as porridge, 
biscuits, cookies, or breakfast cereals made from crushed or rolled oats (Butt et al., 2008). The 
major components of an oat grain are the hull, bran, endosperm and germ (embryo) as shown in 
Figure 2.1. Hull of an oat grain is about 25-30% of the seed. After removal of hulls from oat grains, 
the rest of oat seeds (whole oat groats) are further processed for human consumption or animal 
feed production (Rasane et al., 2015). Whole oat groats contain high amount of valuable nutrients 
such as soluble fibers, proteins, unsaturated fatty acids, vitamins, minerals, and phytochemicals 
(Rasane et al., 2015). Consumption of oat products has been associated with the prevention of 
chronic diseases, such as cardiovascular diseases, diabetes and gastrointestinal disorders; therefore, 
increasing recognition has been given to the health-promoting potentials of oats and oat-derived 
bioactive compounds in recent years (Martínez-Villaluenga and Peñas, 2017). 
 
Figure 2.4 Cross section of an oat grain (Adapted from Butt et al., 2008) 
5 
 
2.1.2 Nutritional compositions 
Oat has a well-balanced nutritional profile. It is a good source of dietary fiber, unsaturated 
fatty acids and phytochemicals (Head et al. 2010). Nutritional components of oats and their 
reported concentrations are shown in Table 2.1. Oat starch comprises approximately 60% of oat 
grain. Notably, it has been reported that oats contain ~ 22% of slowly digestible starch and ~ 25% 
resistant starch of their total starch, which are important for maintaining blood glucose levels and 
improving intestinal health (Ovando-Martinez et al. 2013). Oat is also a good source of lipids, 
most of which are in the endosperm. Oat has higher lipid content, especially unsaturated fatty acids, 
than other cereals, which gives them advantages for being used as a high energy resource with 
beneficial fatty acid composition (Butt et al., 2008). Moreover, phytochemicals in oats also play a 
significant role in health beneficial effects. Most of the phytochemicals have been found in oat 
bran, endosperm and germ (Rasane et al., 2013). Antioxidants such as tocopherols are mostly 
found in oat germ and tocotrienols are mainly found in the endosperm, whereas most phenolic 
compounds are found in oat bran (Rasane et al., 2013). 
Table 2.1 Nutritional compositions of oat groats 
Component Concentration References 
Starch 60% Berski et al. (2011) 
Protein 11-15% Robert et al. (1985) 
Lipid 6-9% Flander et al. (2007) 
Total dietary fiber 
 
10% 
β-glucan: 2.3-8.5% 
Butt et al. (2008) 
Flander et al. (2007) 
Phytochemicals Total tocols: 19.0-30.3 mg/kg 
Phenolic acids: 469-472 mg/kg 
 
Flavonoids: trace amount 
Peterson (2001) 
Peterson (2001) 
Matilla et al. (2005) 
Matilla et al. (2005) 
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2.1.3 Oat antioxidants 
Until recently oat grains have been recognized as important contributors of dietary 
antioxidants, even though they constitute a staple dietary component for most of the world’s 
population (Lorenz and Lee, 1977). Although most of the health benefits of oats are attributed to 
the cholesterol-lowering potential of β-glucan, several phytochemicals have also been found and 
recognized for their positive impacts on human health, which include antioxidants and phenolic 
compounds (Peterson, 2001; Rasane et al., 2015; Martínez-Villaluenga and Peñas, 2017). Because 
most phenolics are found in the bran layer of oat grains, oats could be a significant source of dietary 
antioxidants as they are normally consumed as whole-grain cereal (Peterson, 2001). Several 
phytochemicals have been found in oat groats that show antioxidant activity. The most abundant 
antioxidants are tocols (tocopherols and tocotrienols), phytic acids, phenolic acids, and 
avenanthramides (Avns) (Collins et al., 1991; Peterson, 2001). Also, trace amounts of flavonoids 
and sterols are present in oat groats (Knights and Laurie, 1967; Andlauer & Furst, 1998).  
Tocols are a group of lipid-soluble monophenols that are strong antioxidants generally 
called vitamin E, which are composed of a polar chromanol ring linked to an isoprenoid-derived 
hydrocarbon chain (Figure 2.2) (Tappel, 1962; Shahidi and de Camargo, 2016). A study found that 
total tocols concentrations ranged from 19.0-30.3 mg/kg among 12 oat genotypes in the U.S.A 
(Peterson and Qureshi, 1993), while another study reported a range of 16-94 mg/kg tocol found in 
European oat cultivars, with these differences in concentration being attributed to genotype and 
location (Redaelli et al., 2016). The primary tocol of oat is -tocotrienol with a lesser amount of  
-tocopherol. Almost all of the tocopherols are found in the germ of oat groats, whereas most of 
the tocotrienols are located within the endosperm (Peterson, 1995). 
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Figure 2.5 General structures of tocopherols and tocotrienols 
 
Phenolic acids, which are also abundant in oats, are a group of hydroxyl derivatives of 
aromatic carboxylic acids. The concentration of total free phenolic acids in oat groats was found 
to be 8.7 mg/kg, which was much lower than soluble phenolic acid esters (20.6 mg/kg) and 
insoluble phenolic acids (57.7 mg/kg) (Sosulski et al., 1982). Similarly, several studies identified 
traces of free ferulic, vanillic, and p-coumaric acids with less than 3 mg/kg in oats (Durkee and 
Thivierge, 1977; Dimberg et al., 1996; Emmons and Peterson, 1999), whereas the bulk of ferulic, 
vanillic, sinapic, p-coumaric, and p-hydroxybenzoic acids were found as soluble or insoluble 
bound forms, which were released by alkaline hydrolysis or by β-glucosidase (Sosulski et al., 
1982). Thus, most phenolic acids in oat are present as simple soluble esters and complex insoluble 
esters conjugated with polysaccharides, proteins, or cell walls (Peterson, 2001). Phytic acid is 
another major antioxidant found in whole oat grains. It is a saturated cyclic acid that is the principle 
storage form of phosphorus in many plant tissues, especially bran and seeds (Lolas et al., 1976). 
Although phytic acid is often considered as an anti-nutrient because it binds minerals in the 
digestive tract, making them less available to our bodies, it may also serve as a potent antioxidant 
because it suppresses iron-catalyzed oxidative reactions by forming an iron chelate (Saastamoinen 
et al., 1992). Several studies have measured phytic acid concentrations in oat cultivars and found 
a range of 5.6-12.7 mg/g in oat groats (Lolas et al., 1976; Miller et al., 1980; Saastamoinen et al., 
1992). Another important group of antioxidants in oat are the avenanthramides. They were first 
identified in 1989 by Collins, who named them avenanthramides (Collins, 1989). They are a group 
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of phenolic compounds exclusively found in oats and exhibit high antioxidant activity. They will 
be discussed in detail in the section 2.1.4. 
 
2.1.4 Avenanthramides: polyphenols found exclusively in oats 
Avns are a group of low molecular weight, soluble phenolic compounds found exclusively 
in oats (Collins, 1989). Avns are conjugates of a phenylpropanoid (p-coumaric, ferulic, or caffeic 
acid) with anthranilic acid or 5-hydroxy anthranilic acid (Collins, 1989). The majority of Avns can 
be found in oat groats, with the highest concentration in the bran. More than 20 different forms of 
Avns have been identified in oats (Ishihara et al., 1983; Collins, 1989; Bratt et al., 2003; Peterson 
and Dimberg, 2008). The complete structures of the three most abundant avenanthramides have 
been determined and identified as Avn A, B and C (Collins, 1989; Figure 2.3). Chu et al. 
investigated concentrations of the three major Avns in seven common oat cultivars in Canada and 
found that the Avn A content ranged from 1.05-43.77 mg/kg, Avn B ranged from 3.66-58.63 mg/kg 
and Avn C ranged from 3.7-48.41 mg/kg (2013). Dimberg et al. (1996) reported the concentration 
ranges of Avn A, B and C in three Swedish oat cultivars as 25-47 mg/kg, 21-43 mg/kg and 21-43 
mg/kg, respectively. In addition, four oat cultivars in U.S.A were also investigated for their Avn 
A, B and C contents and the average concentrations were found as 54 mg/kg, 36 mg/kg and 52 
mg/kg, respectively (Emmons and Peterson, 1999).  
A number of studies have been focused on investigating health promoting effect of Avns 
or Avn-enriched oat extracts. It has been found that Avns had strong antioxidant activities in vitro 
with Avn C being the highest (Dimberg et al., 1993; Peterson et al., 2002; Lee-Manion et al., 2009; 
Yang et al., 2014). Moreover, both oat phenolic-rich extracts and pure Avns showed anti-
inflammatory activity by reducing the expression of pro-inflammatory cytokines and repressing 
NF-κB function (Guo et al., 2008; Sur et al., 2008; Chu et al., 2013; Yang et al., 2014). In addition, 
Avn C was reported to inhibit the proliferation of rat vascular smooth muscle cells through 
modulation of cell cycle, indicating the potential health benefit of oat consumption in the 
prevention of coronary heart disease (Nie et al, 2006a; 2006b). Notably, the structures of Avns are 
very similar to a synthetic anti-allergic drug called Tranilast (Figure 2.3), which also has been 
found to have anti-proliferative effect on rat vascular smooth muscle cells (Tanaka et al., 1994). 
Recently, the antiproliferative effects of Avns have also been examined on several cancerous cell 
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lines and found that Avn C was able to decrease the proliferative rates of colonic cancer cell lines, 
including Caco-2, HT29, LS174T, HCT116 (Guo et al., 2010) and MDA-MB-231 breast cancer 
(Hastings and Kenealey, 2017). These findings make Avns promising candidates for therapeutic 
use and the development of nutraceutical products. 
 
Figure 2.6 Chemical structures of Avn A, B & C and Tranilast (Adapted from Peterson, 2001) 
 
2.2 Oxidative stress and antioxidant defense systems 
2.2.1 Free radicals, oxidative stress and human diseases 
A free radical is any atom or molecule that has a single unpaired electron in an atomic 
orbital (Bagchi and Puri, 1998). Free radicals and other reactive oxygen species (ROS) are derived 
either from normal metabolic processes in the human body or from external sources such as X-
rays, ozone, cigarette smoking, air pollutants, and industrial chemicals (Bagchi and Puri, 1998; 
Lobo et al., 2010). Many ROS are unstable and highly reactive, such as hydroxyl radicals (•OH), 
superoxide anions (O2•-) and H2O2. They cause cellular damage by attacking important 
macromolecules leading to homeostatic disruption. Targets of free radicals in the body include 
lipids, nucleic acids, proteins and cell membranes (Yong and Woodside, 2001). Several 
antioxidant defense systems (detailed discussion in 2.2.2 and 2.2.3) are responsible for regulating 
ROS and maintaining the survival and health of cells or organisms; however, when the production 
of ROS exceeds the capacity of the antioxidant defense, oxidative stress occurs, leading to the a 
number of human diseases (Bagchi and Puri, 1998; Yong and Woodside, 2001). It has been found 
and verified by numerous scientific evidence that free radicals are strongly associated with more 
than sixty different health conditions, including the aging process (Finkel and Holbrook, 2000), 
cancer (Wiseman and Halliwell, 1996; Kennedy et al., 1998), diabetes (Leinonen et al., 1997; 
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Hannon et al., 1998), Alzheimer’s disease (Price et al., 1998; Huang et al., 2016), stroke (Allen 
and Bayraktutan, 2009), heart attack and atherosclerosis (Napoli, 1997; Fu et al., 1998). As such, 
antioxidant defenses are absolutely critical for disease prevention and human health. 
 
2.2.2 Antioxidant defense systems 
2.2.2.1 Enzymatic antioxidants  
Several endogenous defense mechanisms have been identified to help protect against free 
radical-induced cell damage in our body. Antioxidant enzymes are one of the endogenous 
components that stabilize or deactivate free radicals before they cause cellular damage (Matés et 
al., 1999). They stabilize free radicals by reducing the energy of free radicals or by donating 
electrons for pairing. In addition, they may also interrupt the oxidizing chain reaction to minimize 
the damage caused by free radicals (Matés et al., 1999). Enzymatic antioxidants include 
superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT) and glutathione 
synthetase (GSS), and their biosynthesis can be induced by H2O2 inside cells (Krishnamurthy and 
Wadhwani, 2012).  
SOD is a group of metal-containing antioxidant enzymes that can add or remove an 
electron from highly reactive O2•- to generate the less reactive species oxygen (O2) and H2O2, with 
the latter further degraded by other antioxidant enzymes (Matés et al., 1999; Figure 2.4). Three 
isoforms of SOD were found in all eukaryotic cells and have been identified as SOD1 (cytosolic 
Cu/Zn-SOD), SOD2 (mitochondrial Mn-SOD) and SOD3 (extracellular SOD) (Matés et al., 1999). 
SOD2 (Mn-SOD) is a homotetramer found in mitochondria that contains one manganese ion per 
subunit. As the mitochondrion is a major site for cellular respiration using oxygen, SOD2 plays an 
essential role for clearing mitochondrial oxygen radicals and, as a result, protect against cell 
damage or death. SOD1 (Cu/Zn-SOD) is a homodimer with a Cu/Zn site in each subunit 
(Krishnamurthy and Wadhwani, 2012). It is believed to play a major role in the first line of 
antioxidant defense. Notably, SOD1 may not be essential for life as Cu/Zn-SOD knockout mice 
appeared normal and exhibited differences only after traumatic injury, whereas Mn-SOD 
knockouts died in three weeks (Li et al., 1995). SOD3 is an extracellular SOD that can be found 
in extracellular fluids such as plasma and lymph. SOD3 is a Cu/Zn containing antioxidant enzyme, 
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but unlike SOD1, it is regulated by cytokines instead of oxidants (Krishnamurthy and Wadhwani, 
2012).  
Peroxide generated by SODs can be subsequently converted to water by CAT or GPx 
catalytic reactions (Matés et al., 1999). CAT is a tetrameric enzyme that contains a 
ferriprotoporphyrin per subunit (Putnam et al., 2000). It efficiently reacts with H2O2 to form water 
and oxygen as shown in Figure 2.4. GPx is a selenium-containing antioxidant enzyme that uses 
glutathione (GSH) to catalyze the reduction of peroxide (Otto et al., 1983; Matés et al., 1999; 
Figure 2.5), thereby protecting cells from damage caused by oxidative stress. As a result, SODs, 
GPx and CAT work together to remove superoxide and peroxides before they cause cellular 
damage.  
 
Figure 2.7 Enzymatic reactions catalyzed by superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GPx) (Adapted from Borowicz et al., 2016) 
 
2.2.2.2 Non-enzymatic antioxidants 
Non-enzymatic antioxidant defense systems can be classified into two categories: 
metabolic antioxidants and dietary antioxidants. Metabolic antioxidants are non-enzymatic 
molecules inside cells or blood plasma that provide rapid inactivation of free radicals and oxidants, 
including but not limited to, glutathione, myoglobin, ferritin, uric acid, and albumin (Mirończuk-
Chodakowska et al., 2018). Dietary antioxidants are exogenous antioxidants such as ascorbic acid, 
vitamin A, vitamin C, α-tocopherol, and plant polyphenols, which are usually obtained from 
consumed fruits, vegetables, beverages and cereal products (Mirończuk-Chodakowska et al., 
2018).  
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Usually endogenous antioxidant defense systems are inadequate without engaging 
exogenous reducing compounds such as vitamin C, vitamin E, carotenoids and polyphenols. 
Polyphenols are the most abundant antioxidants in our diet and they are well recognized for their 
antioxidant properties. Phenolic rings are the functional groups capable of accepting free radicals, 
becoming phenoxyl radicals (Flora, 2009). These radicals are stabilized by resonance 
delocalization of the electrons within the aromatic ring and create quinones. In addition, the 
phenoxyl radicals can also enter into other reactions where the radicals could be neutralized, such 
as dimerization or radical substitution (Flora, 2009). In this way, subsequent free-radical chain 
reactions are inhibited, and oxidation is retarded. A general mechanism is shown in Figure 2.5. 
 
Figure 2.8 Phenolic antioxidant reaction mechanism (Adapted from Kurek-Gorecka et al., 2014) 
 
2.2.3 Plants as sources of dietary antioxidants 
Plants develop their antioxidant systems in an evolutionary manner based on their need to 
survive oxidative stresses generated from the environment (e.g. temperature and light) and 
themselves (transition metals) (Nakatani, 2003). A wide variety of naturally occurring antioxidants 
in plants have been identified with differences noted in structure, physical and chemical properties, 
mechanism of action and site of activity (Brewer, 2011). Polyphenols are the most abundant 
antioxidants in our diet. Their total dietary intake could be as high as 1 g/d, which is much higher 
than all other types of dietary antioxidants. For example, the daily intake of polyphenols in our 
diet is ∼10 times higher than the intake of vitamin C and 100 times higher than the intakes of 
vitamin E and carotenoids (Manach et al, 2004). In our diet, the main sources of polyphenols are 
fruits, vegetables, whole grains and other types of foods and beverages derived from them, such 
as red wine (rich in resveratrol), extra virgin olive oil (rich in hydroxytyrosol), chocolate and tea, 
particularly green tea (rich in epigallocatechin gallate) (Scalbert and Williamson, 2000). Most 
polyphenols derived from plants possess excellent antioxidant properties and several polyphenols 
can also function as signaling molecules that regulate gene expression (Gillespie et al., 2016). 
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2.2.4 Determination of antioxidant activities 
2.2.4.1 DPPH & ABTS free radical scavenging activities 
Antioxidant activity (capacity or potential) is widely used as a parameter to characterize 
different plant foods (fruits, vegetables, wines, teas, oils, etc.). This activity is based on the 
chemical composition of the foods materials that are capable of protecting a biological system 
against the potentially harmful effects of processes and reactions such as oxidation and the 
production of reactive oxygen and nitrogen species (Huang et al. 2005). In vitro free radical 
scavenging tests are one of the most common methods used to measure the antioxidant activity of 
a biological material/extract. The two most widely used chemical compounds to measure the 
antioxidant activity of biological materials are the chromogens, ABTS• + and DPPH• radicals. The 
DPPH (2,2-diphenyl-1-picryl-hydrazyl-hydrate; Figure 2.6-a) free radical method is an antioxidant 
assay based on an electron-transfer mechanism that produces a violet solution in a protic solvent 
such as ethanol (Huang et al. 2005). The DPPH radical is stable at room temperature and is reduced 
in the presence of an antioxidant, leading to a decrease in the intensity of the initial colour of the 
sample solution. The ABTS free radical assay is based on the scavenging ability of antioxidants 
for the stable radical cation ABTS• + [2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid); 
Figure 2.6-b]. The mechanism of the reaction is based on electron transfer from sample 
antioxidants to ABTS• + and it measures the ability of sample antioxidants that react directly with 
the ABTS• + radical to decrease the reaction solution colour (Sharma and Singh, 2013). 
a.                                             b. 
 
Figure 2.9 Chemical structures of DPPH· free radical (a) and ABTS• + free radical (b) (Adapted 
from Huang et al. 2005) 
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2.2.4.2 Intracellular antioxidant activity 
Although DPPH and ABTS assays provide a relatively simple way to estimate the 
antioxidant activities of compounds, they do not mimic biological systems. Without data on their 
bioavailability and cellular impact, the relevance of this information to antioxidant effectiveness 
in organisms is very limited. Therefore, an understanding of how antioxidants perform within cells 
is essential. Exogenous antioxidants are mainly derived from food sources such as vitamins and 
polyphenols, and they have to be absorbed and distributed to the sites where the radicals are, in 
order to be effective (Matés et al., 1999). Several polyphenols have been proven to have the ability 
to effectively scavenge free radicals before they cause damage to cell components.  
One of the fastest and accessible methods for monitoring ROS production intracellularly 
is based on the detection of ROS-sensitive fluorescent probes. These probes react with ROS, 
forming intermediate probe-derived radicals that are successively oxidized to generate the 
corresponding fluorescent products (Wardman, 2007). In addition, intracellular antioxidant 
activity can also be evaluated through antioxidant enzyme activities. Several studies have shown 
polyphenols, such as quercetin and resveratrol, have the ability to enhance the activity of 
antioxidant enzymes inside cells so as to increase the intracellular antioxidant activity (Jang and 
Surh, 2001). Chen and colleagues reported that an avenanthramides-enriched mixture extracted 
from oat increased human plasma GSH expression by ~14% (Chen et al., 2007).  
 
2.3 Inflammation 
Inflammation is an essential part of the body's immune systerm responsible for removal of 
harmful stimuli and initiating the healing process. It is a major defense mechanism in the process 
to eliminate endogenous or foreign stimuli, such as a virus, bacteria and damaged cells, and initiate 
tissue repair (Medzhitov, 2008). There are two types of inflammation in humans: acute and chronic 
inflammation. Acute inflammation arises rapidly in response to harmful stimuli and is only present 
for a short term from hours to days. Without acute inflammation, wound healing would be impaired, 
and infections could become lethal; however, if inflammation persists longer than necessary, it can 
bring more harm than benefit (Medzhitov, 2008). Prolonged inflammation, known as chronic 
inflammation, refers to low-grade long-term inflammation and can last for several months and 
even years. 
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2.3.1 Chronic inflammation 
Chronic inflammation can be caused by a number of factors. If the acute inflammatory 
response fails to eliminate the harmful stimuli, the inflammatory process persists and turns into 
chronic inflammation (Kim et al., 2006). Chronic inflammation can also result from autoimmune 
responses that mistake own antigens as pathogens, leading to the attack of normal healthy tissues. 
Notably, chronic inflammation is widely observed in obesity. Studies revealed that fatty deposits 
can trigger autoimmune response, in which the immune system mistakes fatty deposits for 
intruders and starts to attack adipose cells (Greenberg and Obin, 2006; Rogowski, 2010). The 
damaged adipose cells recruit macrophages and assist in releasing inflammatory cytokines, 
including Tumor necrosis factor α (TNFα) and interleukin 6 (IL-6), which further induce 
inflammation (Greenberg and Obin, 2006; Stolarczyk, 2017). Moreover, chronic inflammation is 
often associated with environmental or habitual factors, such as excess weight, poor diet, lack of 
exercise, stress, smoking, industrial chemicals and pollution (Ruiz-Núñez et al., 2013). Unlike 
acute inflammation, chronic low-grade inflammation often does not have symptoms, but it can 
eventually cause many diseases and conditions such as diabetes, rheumatoid arthritis, 
atherosclerosis and cancer (Salminen et al., 2008). 
Increasing evidence has shown that diabetes is an inflammatory disease (Zhong et al., 
2017). Type 1 diabetes is caused by autoimmune-mediated chronic inflammation, leading to the 
destruction of pancreatic β cells and insufficient secretion of insulin (Batch, 1994). Type 2 diabetes, 
characterized by insulin resistance, has been linked to obesity and chronic low-grade inflammation 
in peripheral tissues (e.g. skin) (Hotamisligil et al., 1993). Chronic inflammation is also strongly 
associated with cardiovascular diseases. When cholesterol deposits in the lining of blood vessels, 
it is recognized as an insult and triggers inflammatory responses. Fatty plaques accumulate in 
inflamed blood vessels and cause blockages and blood clots, which leads to heart attacks (Libby, 
2006). In addition to diabetes and cardiovascular diseases, bone loss is another consequence of 
chronic inflammation. It has been shown that cytokines produced by chronic inflammation impair 
bone remodeling, in which damaged parts of bones are replaced with new ones (Hardy and Cooper, 
2009). Furthermore, intestinal inflammation can interfere with calcium and vitamin D absorption, 
which are important to bone health (Irwin et al., 2016). 
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2.3.2 Inflammatory cytokines 
Inflammation is controlled by a number of extracellular signaling mediators and regulators, 
including cytokines, growth factors and peptides. Cytokines are a group of small proteins released 
by cells that act as chemical messengers for communications and interactions between cells. They 
are key modulators of inflammation, participating in both acute and chronic inflammation through 
a complex network of interactions and signaling pathways (Turner et al., 2014). Cytokines are 
produced by a broad range of cells, including immune cells like macrophages, B lymphocytes, T 
lymphocytes, as well as endothelial cells, fibroblasts, and various stromal cells (Lawrence, 2009). 
Cytokines are commonly classified as pro-inflammatory cytokines and anti-inflammatory 
cytokines. Pro-inflammatory cytokines such as interleukin 1 beta (IL-1β), IL-6, interleukin 8 (IL-
8) and TNFα promote inflammatory responses, whereas anti-inflammatory cytokines such as IL-
1 receptor antagonist, and interleukins 4, 10, 11 and 13 are responsible for supressing the activity 
and synthesis of pro-inflammatory cytokines (Turner et al., 2014). A balance between pro-
inflammatory and anti-inflammatory cytokines is important to maintain cellular and organismal 
health.  
 
2.3.3 NF-κB signaling  
NF-B is a family of eukaryotic nuclear transcription factors that regulate the transcription 
of deoxyribonucleic acid (DNA) and are involved in activation of the genes related to 
inflammatory and immune responses (Li and Verma, 2002). There are two pathways for the 
activation of NF-B, known as the classical (canonical) pathway and the alternative (non-
canonical) pathway. NF-B consists of p65 and p50 subunits, and it is mainly involved in natural 
immunity and general inflammation (Li and Verma, 2002). Inhibitor of B (IB) is an protein that 
is bound to NF-B and inhibits its function under non-stress conditions. Upon stress, IB is 
phosphorylated and degraded by 26S proteasome, liberating the active NF-B transcription factor 
subunits to translocate to the nucleus and drive the expression of genes encoding pro-inflammatory 
cytokines, such as IL-1β, IL-6, IL-8 and TNFα (Gilmore, 2006; Figure 2.7). Activation of NF-B 
leads to the inflammation process involved in many diseases, such as asthma, rheumatoid arthritis 
and bowel disease (Yamamoto and Gaynor, 2001). Plant polyphenols such as curcumin, resveratrol 
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and green tea catechins have been found to be potent inhibitors of NF-B by preventing the 
degradation of IB (Aggarwal and Shishodia, 2006).  
 
Figure 2.7 Canonical NF-B activation pathways. IKK: IκB kinase; R: receptor (Adapted 
from Lawrence, 2009) 
 
2.4 Nrf2/HO-1 system in cytoprotection 
Heme oxygenase (HO), encoded by the HMOX gene, is an evolutionarily conserved 
enzyme that catabolizes heme into ferrous (Fe2+), carbon monoxide (CO), and biliverdin 
(Tenhunen et al., 1968; Figure 2.8). Two isoforms of HO have been identified; one is the 
constitutively expressed form (HO-2) and the other is the inducible form (HO-1). Cumulative 
evidence has shown that HO-1 is one of the most critical cytoprotective enzymes in human (Morse 
and Choi, 2005; Gozzelino et al., 2010). The major biological function of HO is the degradation 
of free heme. Under oxidative stress, heme groups can be released from hemoproteins and catalyze 
the production of free radicals, leading to cellular damage, and HO-1 keeps free heme at a 
relatively low level for cellular protection (Gozzelino et al., 2010). Besides the reduction of free 
heme, HO-1 also exerts cytoprotective effects through the generation of three metabolites during 
the heme degradation process that are involved in health promotion (Figure 2.8). Ferrous ions 
produced by HO activity upregulates the expression of ferritin, which catalyzes the oxidation of 
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iron from the ferrous form (Fe2+) to the ferric form (Fe3+) (Harrison and Arosio, 1996). In addition, 
ferritin can bind free heme that prevents cellular damage (Harrison and Arosio, 1996). Carbon 
monoxide generated from heme degradation has shown anti-inflammatory, antiapoptotic, and 
antiproliferative effects through regulating p38𝛽 and mitogen-activated protein kinase (MAPK) 
pathways (Piantadosi, 2008). Additionally, CO protective effects were observed in many cell types 
through decreased levels of ROS (Piantadosi, 2008). Biliverdin, the precursor of bilirubin, has 
been reported to have antiviral activity, and bilirubin is now recognized as a potent antioxidant in 
the body (Stocker et al., 1987). A number of studies observed that HMOX 1 knockout mice 
developed severe pathologic conditions, resulting in a high incidence of mortality (Poss and 
Tonegawa, 1997; Wiesel et al., 2000), indicating that HO-1 plays an important role on maintaining 
homeostasis of normal physiological conditions (Soares and Bach, 2009) 
 
Figure 2.10 Heme degradation catalyzed by heme oxygenase (Adapted from Soare and Bach, 
2009) 
 
NF-erythroid 2-related factor 2 (Nrf2) is a transcription factor that regulates expression of 
many antioxidant and detoxifying enzymes including HO-1 (Itoh et al., 1997). Under unstimulated 
conditions, Nrf2 is sequestered by its inhibitor Kelch-like-ECH-associated protein 1 (Keap1) in 
cytoplasm that inhibits translocation of Nrf2 to the nucleus, and Nrf2 is subject to proteasomal 
degradation by ubiquitin (Ub) (Itoh et al., 1997; Niture et al., 2009). Nrf2 becomes 
transcriptionally active through multiple mechanisms including direct phosphorylation and loss of 
contact between Nrf2 and Keap1. Upon activation, Nrf2 is able to enter the nucleus and bind 
antioxidant response element (ARE) together with Maf protein to drive the expression of target 
genes such as HMOX1 and NQO1 (Itoh et al., 1997; Ma, 2013). As a result, Nrf2 activation leads 
to decreased overall oxidative stress and inflammation. A widely accepted model for induction of 
ARE-mediated antioxidant gene expression involves phosphorylation of serine/threonine residues 
of Nrf2 by protein kinases, leading to enhanced nuclear accumulation of Nrf2 and subsequent ARE 
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binding (Niture et al., 2009). A general mechanism of Keap1-Nrf2 system under stressed and 
unstressed conditions is shown in Figure 2.9.  
 
Figure 2.11  Keap1-Nrf2 system for the regulation of cytoprotective genes. (Adapted from Ma, 
2013) 
 
2.5 Nutrient sensing at cellular level 
Nutrition can positively influence human health and lower the risks associated with 
exposure to mixtures of environmental chemicals. In nutrigenomics, nutrients are seen as signaling 
molecules that function in a specific cell in the body (Neeha and Kinth, 2013). The nutrients are 
detected by many sensor systems in cells. The sensory systems that interpret information from 
nutrients include transcription factors. Once the nutrient interacts with such a sensory system, it 
impacts gene expression and metabolite production. As a result, different nutrients change 
different patterns of gene expression and metabolite production (Van Ommen and Stierum, 2002). 
Current research is now focused on how nutrients impact the expression and action of specific 
genes and how these proteins in turn affect the response to nutrients. Although numerous bioactive 
compounds have been shown to have health-promoting potential, more scientific research needs 
to be conducted before we can begin to make science-based dietary recommendations. This 
scientific evidence will provide consumers with food choices for disease prevention and improved 
health that match their lifestyles, cultures and genetics. 
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2.5.1 Polyphenols on gene regulation 
Phenolic compounds in foods have attracted great interest recently due to growing evidence 
of their beneficial effects on human health. Polyphenols, which are the most abundant antioxidants 
in our diet, possess a wide variety of structures, and physical and chemical properties (Brewer, 
2011). Most of the evidence on the beneficial effects of dietary polyphenols is derived from 
experiments performed in vitro or in animal models. Many polyphenols have been demonstrated 
to have anti-inflammatory, anti-allergenic, anti-aging, and anticarcinogenic activities (Guo et al., 
2009). The broad therapeutic potentials of most polyphenols are largely attributed to their 
antioxidant properties. In addition to an antioxidant effect, several polyphenols may act as 
signaling molecules that influence gene expression independent of their free radical scavenging 
activity (Aggarwal and Shishodia, 2006; Gillespie et al., 2016).  
Resveratrol (3,4’,5-trihydroxy-trans-stilbene) consists of two aromatic rings which are 
attached by a methylene bridge. It is one of the most well-known and well-studied polyphenols 
commonly found in red wine, red grape skin, peanuts and berries (De la Lastra and Villegas, 2005). 
Increasing research interest on resveratrol started from the “French paradox”, which describes 
improved cardiovascular health in French people despite their high-fat diets. Since then, 
resveratrol has been explored for its health-promoting and disease prevention effects. Numerous 
studies show that resveratrol exhibits antioxidant, anti-inflammatory, antiproliferative and anti-
aging potentials from both in vitro and in vivo experiments (Zhu et al., 2011; Minagawa et al., 
2015; Park et al., 2016). Besides the free radical scavenging capability of resveratrol, an important 
antioxidant mechanism of resveratrol has been reported as the suppression of the pro-oxidative 
enzyme NADPH oxidase and the induction of antioxidant enzymes SOD1 and GPx1 (Spanier et 
al., 2009). Moreover, resveratrol also supresses inflammation through reducing NF-κB activation 
or inhibiting translocation of NF-κB from the cytosol to the nucleus (Zhu et al., 2011; Minagawa 
et al., 2015). This inhibitory effect is likely due to the activation of Sirtuin 1 (SIRT1)-mediated 
deacetylation of p65 subunit of NF-κB, phosphorylation of NF-κB and stabilization of IκB 
(inhibitor of NF-κB), leading to the downregulation of pro-inflammatory cytokine gene expression 
(De la Lastra and Villegas; 2005; Zhu et al., 2011). Recent research has been driven to exploration 
of anti-aging potential of resveratrol. In 2003, Howitz and Sinclair showed that resveratrol 
significantly extends the lifespan of Saccharomyces cerevisiae (Howitz et al., 2003). Later the 
positive effect of resveratrol on the lifespan has been observed in a worm Caenorhabditis elegans, 
21 
 
a fruit fly Drosophila melanogaster (Wood et al., 2004; Gruber et al. 2007) and a short-lived fish 
Nothobranchius furzeri (Valenzano et al., 2006). The mechanisms for the lifespan extension are 
associated with the activation of Sirtuin deacetylases directly or indirectly by resveratrol (Pacholec 
et al., 2010). The activation of Sirtuin by resveratrol also associates with activation of autophagy, 
which is mediated by SIRT1 activation and the mammalian target of rapamycin (mTOR) inhibition 
(Park et al., 2016). 
 Epigallocatechin gallate (EGCG), also known as epigallocatechin-3-gallate, is another 
well-known dietary polyphenol mostly found in green tea. It is a type of catechin and made of the 
ester of epigallocatechin and gallic acid. Various health benefits and molecular targets of EGCG 
have been proposed based on studies in cell lines and animal models. Similar to resveratrol, EGCG 
can reduce cellular oxidative stress by up-regulating antioxidant enzymes through Nrf2/ARE 
pathway (Zheng et al., 2012). In addition, EGCG decreases inflammatory response by inhibition 
of NF-B pathway and regulation of cyclooxygenase 2 (COX-2), thereby reducing the expression 
of genes encoding pro-inflammatory cytokines (Li et al., 2004). EGCG has also been reported to 
function as a signaling molecule that triggers cascades of metabolic pathways, leading to the 
inhibition of carcinogenesis. The proposed mechanisms include the inhibition of MAPK and 
phosphoinositide 3-kinase/ protein kinase B (PI3K/AKT) pathways, NF-κB and AP-1-mediated 
transcription, growth factor-mediated signaling (Gupta et al., 2003; Khan et al., 2006; 
Nandakumar et al., 2011). Also, EGCG impacts gene expression by epigenetic modification, 
which also leads to inhibition of tumor cell growth or induction of apoptosis (Fang et al., 2003; 
Nandakumar et al., 2011). Recently, Holczer and colleagues (Holczer et al.,2018) found that 
EGCG promotes autophagy-dependent survival through regulating mTOR/5' AMP-activated 
protein kinase (AMPK) pathways. 
Most of the evidence on the health-promoting effects of dietary polyphenols is derived 
from experiments using concentrations much higher than those generally attainable through diet 
use. Moreover, the polyphenol compounds used in those experiments are often aglycones or their 
sugar conjugates, rather than their effective metabolites. Therefore, more evidence is needed to 
show the effectiveness of polyphenols in disease prevention and human health including their 
bioavailability and the fate of their metabolites and evaluate their biological activity in different 
target tissues.  
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3. MATERIALS AND METHODS 
3.1 Oat samples 
Oat samples of ten varieties and breeding lines were obtained from the Crop Development 
Centre, University of Saskatchewan. They were BW10, BW513, BW5303, CDC Dancer, CDC 
Morrison, CDC Sol-Fi, Jumbo, Marion, Newberg, OT2021.  
 
3.2 Exaction of phenolic compounds from oat samples 
Five (± 0.01) grams of ground powder of each sample was extracted three times with 50 
mL of methanol:phosphoric acid solvent mixture (80:20, v:v; pH 2.1) by magnetic stirring for 30 
min. The sample mixtures were centrifuged for 10 min at 10,000 rpm and the supernatants were 
pooled and evaporated at 40 °C using a Buchi III Rotavapor vacuum evaporator (Brinkmann 
Instruments, Mississauga, ON). The residue was re-suspended in 5 mL of the extraction solvent 
and centrifuged at 10,000 rpm for 10 min. The final volume of the oat extract was made up to 5 
mL in a volumetric flask with methanol. The oat extract samples were stored in dark at -18 °C for 
future analysis. 
 
3.3 HPLC analysis of Avn A, B and C in oat extracts 
Reversed phase HPLC was performed on an 1100 series HPLC system (Agilent 
Technologies Canada Incorporated, Mississauga, ON), equipped with a photodiode array (PDA) 
detector. Phenolic separation was achieved using a 250 x 4.6 mm Luna® 5 μm, C18 column 
(Phenomenex, Torrance, CA, USA) in series with a C18 guard cartridge (Phenomenex, Torrance, 
CA, USA). Mobile phases consisted of solvent A: H2O with 5% acetonitrile and 0.5% trifluoracetic 
acid by volume; Solvent B: acetonitrile. Samples were run with a linear gradient over 40 min from 
5 to 40 % solvent B in solvent A with a flow rate of 1 mL/min followed by 40 % solvent B in 
solvent A for 5 min. The injection volume was 10 μL. All samples were syringe filtered (0.22 μm 
pore size; 13 mm diameter; Sigma-Aldrich, Oakville, ON, Cat #: F7148) prior to HPLC analysis. 
Standards run in conjunction with the samples included: Avn A (SynInnova, Edmonton, AB, Cat 
#: SL707), Avn B (SynInnova, Cat #: SL337) and Avn C (SynInnova, Cat #: SL340). Standards 
were prepared at the following concentrations: 2.0, 4.0, 6.0, 8.0, 10.0, 20.0 and 40.0 (± 0.02) ppm. 
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Detection was monitored at 340 nm with reference at 700 nm. All samples were analyzed in 
triplicate. 
 
3.4 Total phenolic content of oat extracts 
The Folin-Ciocalteau (FC) method was used to determine total phenolic content of oat 
extract samples. The method was adapted from Singleton et al. (1999). In brief, a 2.0 N stock FC 
solution (Sigma-Aldrich, Cat #: 47641) was diluted 1/10 with water obtained Millipore Milli-Q™ 
water system (Millipore Corporation, Milford, MA, USA). All oat extracts were diluted 1/20 with 
Milli-Q™ water. One hundred and fifty microliters of the diluted oat extract was mixed with 750 
µL diluted FC reagent by vortexing. Six hundred microliters of 15% (w/v) Na2CO3 solution was 
then added followed by vortexing. The samples were then held static at room temperature in the 
dark for 2 h. Following the incubation period, samples were analyzed by UV-visible spectroscopy 
(Genesys 10S UV-visible, Fisher Scientific, Edmonton, AB) at 765 nm. A control was prepared 
which contained all the reagents and 150 µL Milli-Q™ water in place of the diluted samples. Milli-
Q™ water was used as blank. A standard curve was prepared using gallic acid at concentrations 
ranging from 10-50 ± 0.2 mg/L in water, which were analyzed in conjunction with samples. 
Standard curves had correlation coefficients 0.9989. All samples and standards were analyzed in 
triplicate and the results were reported as gallic acid equivalent (GAE). 
 
3.5 2,2'-Azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical scavenging 
activity 
ABTS•+ free radical solution was prepared by mixing 7.0 mM ABTS solution (Sigma-
Aldrich, Cat #: 11557) and 2.45 mM potassium persulfate (Sigma-Aldrich, Cat #: 216224) in a 
ratio of 1:1.  This mixture was held static at room temperature for 12 h in the dark to afford ABTS•+ 
formation.  The resulting ABTS•+ radical cation solution was diluted approximately 1 in 50 with 
70% (v/v) methanol to give an absorbance reading of 0.75 ± 0.05 at 734 nm. Each oat extract 
sample was diluted 1/4, 1/3, 1/2, 1/1 with methanol. The Trolox standard (Sigma-Aldrich, Cat #: 
238813) was prepared in 70% (v/v) methanol at the following concentration range: 0.1 (0.4 mM) 
to 0.5 mg/mL (2.0 mM). Avn A, B and C were prepared from 100 ppm to 1000 ppm in methanol. 
Caffeic acid (Sigma-Aldrich, Cat #: C0625), gallic acid (Fisher Scientific, Cat #: A122-500) and 
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Trolox (Sigma-Aldrich, Cat #: 238813) were used as standards and prepared from 50 to 300 ppm 
in methanol.  
The assay was conducted by mixing 10 μL of the sample solution with 1.0 mL of ABTS•+ 
solution.  The absorbance was read at 734 nm at time intervals of 1, 4 and 6 min.  A control solution 
of 10 µL 70% (v/v) methanol in 1.0 mL ABTS•+ solution was prepared and analyzed at the same 
wavelength. Absorbance values measured at 6 min were used to calculate the percent radical 
inhibition as follows:   
           % ABTS inhibition= [1-(A734nm sample)/ (A734nm control)] ×100 
   Where:  
               A734nm sample = sample absorbance at 734 nm 
              A734nm control = control absorbance at 734 nm 
The % ABTS
•+ inhibition was plotted as a function of sample concentration and resulting 
linear regression equations were determined. Correlation coefficients of the linear regression 
equations were  0.99.  The 50% radical inhibition concentration (IC50) was determined by the 
concentration that resulted in 50% radical scavenging activity using the linear regression curve. 
All samples were analyzed in in triplicate. 
 
3.6 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity 
A 500 µM DPPH solution was prepared by dissolving 9.8 ± 0.2 mg of DPPH (Sigma-
Aldrich, Cat #: D9132) in 70% (v/v) methanol. Fresh DPPH solution was prepared daily for sample 
analysis. Oat extracts were diluted 1/4, 1/3, 1/2 with methanol. Avn A, B and C were prepared 
from 100 to 1000 ppm in methanol. Caffeic acid, gallic acid and Trolox were used as references 
and prepared from 50 to 300 ppm in methanol.  
A 1.0 mL DPPH solution and 0.25 mL sample solution were mixed by vortexing. The blank 
consisted of methanol, and the control was prepared by mixing 1.0 mL DPPH solution with 0.25 
mL of methanol. All samples were held static at room temperature in the dark for 15 min, prior to 
absorbance measurement at 517 nm. The % DPPH radical scavenging activity was calculated as 
follows: 
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% DPPH radical scavenging activity= [1-(A517nm sample)/ (A517nm control)] ×100 
Where: 
A517nm sample = sample absorbance at 517nm 
A517nm control = control absorbance at 517nm 
The IC50 was determined at the concentration that resulted in 50% radical scavenging 
activity using the linear regression curve of % DPPH vs sample concentration. All samples were 
analyzed in triplicate. 
 
3.7 Cell culture 
Normal human skin fibroblasts 2DD cells (previously described in Bridger et al. 1993) 
were grown in high glucose (4.5 mg/mL) Dulbecco’s Modified Eagle Medium (DMEM) (pH 7.7; 
Corning, Manassas, VA, USA, Cat #: ca45000-304) supplemented with 10% (w:w) fetal bovine 
serum (FBS) (Gibco, Thermo Fisher Scientific, Cat #: 12483-020) and 1.0% (w:w) penicillin 
streptomycin (GE Healthcare Life Sciences, Logan, UT, USA, Cat #: SV30010). Cells were seeded 
at an initial density of 3000 cells/cm2 and incubated at 37°C in a humidified with 5% carbon 
dioxide (CO2). Cells were passaged every 3 to 4 days with cells never excessing 80% confluency. 
Cells from passage number 12 to18 were used in experiments. 
Four human cancer cell lines: MCF-7 cells (human breast adenocarcinoma), HCT 116 cells 
(human colon carcinoma), HepG2 cells (human liver hepatocellular carcinoma) and U2OS cells 
(human bone osteosarcoma) were purchased from American Type Culture Collection (Manassas, 
VA, USA) grown in the same media and under the same culture condition as 2DD cells. Culture 
media was changed every 3 to 4 days.  
 
3.8 Cell treatment 
Media used for Avn C treatments was identical to that used for proliferative cultures. Avn 
C stock solution was made by dissolving Avn C in dimethyl sulfoxide (DMSO) to a final 
concentration of 50 mM. DMSO was used as a vehicle control and never exceeded 0.4% (v:v) in 
culture media.  
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3.8.1 Cell treatment for intracellular antioxidant activity assays 
2DD cells were seeded at a density of 3,000 cells/cm2. After 24 h, DMSO or Avn C (100 
and 200 μM) were added into culture media and incubated at 37°C & 5% CO2 for 48 h. Cells were 
then washed two times with serum-free DMEM and hydrogen peroxide solution (H2O2) (Sigma-
Aldrich, Cat #: 216763) was added to serum-free DMEM media at a final concentration of 200 
M with incubation at 37°C in a humidified atmosphere with 5% CO2 for 1 h. Three biological 
replicates were conducted. 
 
3.8.2 Cell treatment for anti-inflammatory activity assays 
2DD cells were seeded at a density of 3,000 cells/cm2. To evaluate anti-inflammatory 
activity of Avn C on 2DD cells, three different treatment conditions were applied: 1) Non-inducing 
conditions: cells were treated with DMSO or Avn C (100 and 200 μM diluted from 50mM Avn C 
stock solution) for 24 h; 2) H2O2-induced conditions: cells were treated with DMSO or Avn C (100 
and 200 μM diluted from 50mM Avn C stock solution) for 48 h, followed by washing with serum-
free DMEM. Hydrogen peroxide in serum-free media was added to achieve a final concentration 
of 200 μM with incubation as above for 1 h to induce cellular stress; and 3) TNFα-induced 
condition: cells were treated with DMSO or Avn C (100 and 200 μM diluted from 50mM Avn C 
stock solution) for 24 hours. TNFα was then added to media to a final concentration of 10 ng/mL 
and incubated for 4 h to induce the expression of pro-inflammatory markers. Three biological 
replicates were conducted. 
 
3.8.3 Cell treatment for anti-proliferative effect assays 
2DD cells and four cancer cells were seeded at a density of 3000 cells/cm2. After 24 h, 
DMSO or Avn C (50, 100 and 200 μM diluted from 50mM Avn C stock solution) were added into 
culture media and incubated for 48 h. Three biological replicates were conducted. 
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3.9 Cell counts and cell viability 
2DD cells and cancer cells were grown in 6-well plates under the previously described 
treatment conditions (3.8.3). At the end of the incubation period, cells were dissociated from the 
plate surface using TrypLE Express (Life Technologies, Carlsbad, CA, USA, Cat #: 12604013) 
and centrifuged at 200 relative centrifugal force (rcf) for 5 min to pellet cells. Cells were then re-
suspended in culture media. Cell counts were conducted using 10 µL of cell suspension on a 0.0025 
mm2 Neubauer improved haemocytometer. To count and calculate total cell number, one drop of 
cell suspension was placed on the hemocytometer and then covered with a piece of cover glass. 
Cell numbers in five of the nine squares were counted. Total cell number was calculated as follows: 
Total number of cells 
=  
Number of cells counted
5
 × volume of cell suspension (mL) × 10,000 
Population doubling time was calculated as follows: 
Population doubling time (h) =  Incubation time (h)  × 
ln(2)
ln(
𝐹𝑖𝑛𝑎𝑙 𝑐𝑒𝑙𝑙 𝑛𝑢𝑚𝑏𝑒𝑟𝑠
𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑐𝑒𝑙𝑙 𝑛𝑢𝑚𝑏𝑒𝑟𝑠)
 
 For cell viability test, cell suspensions were mixed 1:1 with 0.4% (v:v) trypan blue dye 
(VWR International, Cat #: CA97063-702). Total stained and unstained cells were counted by a 
haemocytometer under light microscope. Cells stained dark blue were considered not viable. 
Percentage of viable cells was calculated as follows:  
% Viable cells =  
Total cell numbers − nonviable cell numbers
Total cell numbers
 × 100% 
 
3.10 Immuno-labeling of Ki67 
2DD cells were grown on sterilized 22 mm2 glass coverslips in 6-well dishes under the 
previously described conditions (3.8.3). At the end of the incubation period, cells were fixed with 
3.7% formaldehyde in phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4 and 2 mM KH2PO4; pH 7.4) for 10 min at room temperature, followed by incubation in 
ice-old methanol/acetone (1:1 mixture) for 8 min at 4°C. Cells were washed two times with PBS 
and then permeabilized with 0.5% (v:v) Triton X-100/PBS for 10 min at room temperature. Cells 
were blocked with 1% (v:v) bovine serum albumin (BSA) for 1 h at room temperature. Cells were 
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placed on coverslips and were incubated in rabbit anti-Ki67 (1:2000 dilution; Novacastra, 
Newcastle, UK, Cat #: NCL-Ki67) diluted in 1.0% (v:v) BSA/PBS for 1 h in a dark humidity 
chamber at room temperature. Cells were then washed two times with PBS (1 mL per wash) and 
incubated in goat anti-rabbit A488 (1:200 dilution; Stratech/Jackson Scientific, UK, Cat #: 
111545-003-JIR) diluted in 1.0% (v:v) BSA/PBS for 1 h in a dark humidity chamber. Nuclei were 
counterstained with VECTASHIELD® Mounting Medium with DAPI (4 ′ ,6-diamidino-2-
phenylindole) (Vector Laboratories, Burlingame, CA, USA, Cat #: H1200) onto glass slides and 
sealed with nail varnish. A Nikon Y-IDP microscope fitted with an X-Cite fluorescence light 
source and a Nikon Digital Sight DS-U3 camera was used to collect images. Images were collected 
at 40X magnification with a constant exposure time. Images were imported into ImageJ 
(https://imagej.nih.gov/ij/), an image processing software. An arbitrary threshold was selected and 
any nuclei with a level above this value was considered positive and those below this threshold 
were considered negative. Percentage of Ki67 positive cells was calculated. Three biological 
replicates were conducted. 
 
3.11 MitotrackerTM Orange labeling of intracellular free radicals 
MitoTrackerTM Orange CM-H2TMRos (Molecular Probe, Eugene, OR, USA, Cat #: M-
7511) is a reduced, non-fluorescent dye that stains mitochondria in live cells and becomes 
fluorescent when oxidized. 2DD cells were grown on sterilized 22 mm2 glass coverslips in 6-well 
dishes under the previously described conditions (3.8.1). Coverslips with adhered cells were 
washed two times with serum-free media (2ml per wash). MitoTracker Orange was dissolved in 
DMSO and added to the serum-free media at a final concentration of 500 nM. After incubating for 
30 min, cells on coverslips were fixed and image analysis was conducted as outlined above (3.10). 
Three biological replicates were conducted. 
 
3.12 RNA extraction 
2DD cells were grown in 10 cm diameter plates under the previously described treatment 
conditions (3.8.1, 3.8.2 and 3.8.3). RNA was extracted using TRIzol™ reagent (Life Technologies, 
Cat #: 15596026). Briefly, cells were dissociated from the surface of culture dishes using TrypLE 
Express (Life Technologies, Cat #: 12604013) and centrifuged at 200 x g for 5 min to pellet cells. 
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Cells were then re-suspended in 1 mL of TRIzol reagent and incubated at room temperature for 10 
min. Two hundred microliters of chloroform was added and vigorously vortexed. Samples were 
then centrifuged at 12,000 rcf for 5 min at 4°C. The clear upper-phase was separated from the 
sample and placed in a new 1.5 mL centrifuge tube. RNA was precipitated by adding 1/10 sample 
volume of 3 M sodium acetate (pH 5.2) and 1X sample volume of isopropanol followed by 
incubation on ice for 30 min. Samples were centrifuged at 12,000 rcf for 30 min at 4°C. The 
supernatant was removed, and the resulting pellet of RNA was washed with 75% (v:v) cold ethanol. 
The pellet was air-dried and re-suspended in nuclease-free H2O (Invitrogen, Cat #: 10977-015). 
Samples were then treated with DNase I (Roche, Mannheim, Germany, Cat #: 04716728001) at 
37°C for 20 min to remove any DNA residues. Same sample volume of acid-phenol:chloroform 
(5:1, pH 4.5) (Life Technologies, Carlsbad, CA, USA, Cat #: AM9720) was added to samples and 
centrifuged at 12,000 rcf for 5 min at 4°C and the clear upper-phase was separated from the sample. 
RNA was precipitated by adding 1/10 sample volume of 3 M sodium acetate (pH 5.2) and 2.5 
times sample volume of ethanol followed by incubation overnight at -20°C. Samples were 
centrifuged at 12,000 rcf for 30 min at 4°C and re-suspend in nuclease-free water. RNA 
concentration was determined using a NanoDrop™ 2000 Spectrophotometer (Thermo Fisher 
Scientific, Wilmington, DE, USA) and aliquots stored at -80°C. The quality of RNA samples was 
determined by sample analysis on a 1% agarose gel. RNA samples that showed sharp and clear 
28S and 18S ribosomal RNA (rRNA) bands were used for cDNA synthesis. A representative gel 
is shown in Figure 3.1 with the 18S and 28S rRNA bands being both sharp and clear. 
 
Figure 3.1 Gel electrophoresis of total RNA samples 
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3.13 cDNA synthesis 
Two milligrams of RNA samples from 3.10 were used in complementary DNA (cDNA) 
synthesis reactions in combination with random hexamers and SuperScript™ III Reverse 
Transcriptase (Invitrogen, Carlsbad, CA, USA, Cat #: 18080044). In brief, 2 g total RNA, 1 L 
of 50 ng/L random hexamers, 1 L 10 mM of each dATP, dGTP, dCTP, dTTP were mixed and 
made up to 13 L with nuclease free H2O. The mixture was incubated for 5 min at 65°C. A master 
mix of 4 μL 5X First-Strand Buffer, 1 L 0.1 M DTT, 1 μL RNaseOUT™ Recombinant 
Ribonuclease Inhibitor (Invitrogen, Cat #: 10777019) and 1 L of SuperScriptTM III Reverse 
Transcriptase (200 U/L) was added to a total reaction volume of 20 L. Samples were incubated 
at 25°C for 5 min, 50°C for 60 min and 70°C for 15 min. Synthesized cDNA was diluted to a total 
volume of 200 L with nuclease-free water and stored at -20°C until analysis. 
 
3.14 Quantitative polymerase chain reaction (qPCR) 
qPCR was performed following cDNA synthesis (3.10). A series of 10 L reactions were 
set up using 5 μL PerfeCTa® SYBR® Green SuperMix for iQ (Quantabio, Beverly, MA, USA, Cat 
#: 95053-500), 2 μL cDNA template, 2 μL nuclease-free H2O and 1 μL of 3 μM of each forward 
and reverse primers. qPCR reactions were conducted using a Rotor-Gene® Q qPCR (Qiagen, 
Germantown, MD, USA). All reactions for each gene were run in triplicate with non-template 
controls. Melt curve analyses were conducted to confirm the presence of single products in each 
reaction. Results were quantified using the ΔΔCt method against two normalizing genes: SPARC 
and FKBP10. The fold change values were calculated as follows:  
ΔCt treatment sample = Ct target gene in treatment sample - Ct normalizing gene in treatment sample   
ΔCt control sample = Ct target gene in control sample - Ct normalizing gene in control sample 
ΔΔCt = ΔCt treatment sample - ΔCt control sample 
Fold change = 2−ΔΔCt 
 
The sequences of the primers used for qPCR were designed by Primer 3 (version 0.4.0; 
http://bioinfo.ut.ee/primer3-0.4.0) software and are listed in Table 3.1. qPCR data for each gene 
of interest were obtained from three independent biological replicates.  
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Table 3.2 Primers for RT-qPCR 
Gene Forward primer 
(5’→3’) 
Reverse primer 
(5’→3’) 
Amplicon 
(bp) 
Normalizing genes 
SPARC TACATCGGGCCTTGCAAATAC GGTGACCAGGACGTTCTTGAG 99 
FKBP10 GCCGTGCTAATCTTCAACGTC GGTGGTCTCATTGCAGGTCTC 105 
Antioxidant enzyme genes 
GSS AGCTTTCCATCTGAGGACCAG TCCTATCCCAAGTCAGGCACT 188 
HMOX1 AAAGGAGGAAGGAGCCTATGG AGCTGCCACATTAGGGTGTCT 149 
SOD1 GGCAAAGGTGGAAATGAAGAA GGGCCTCAGACTACATCCAAG 112 
GPx1 CCTCCCCTTACAGTGCTTGTT GAGAAGGCATACACCGACTGG 115 
CAT TGCAAGCTAGTGGCTTCAAAA TCCAATCATCCGTCAAAACAA 143 
Pro-inflammatory cytokine genes 
IL-1β GCTACGAATCTCCGACCACCA AACCAGCATCTTCCTCAGCTTG 91 
IL-6 CGTCCGTAGTTTCCTTCTAGCTT CAAAGGAGGACCTTGTGGCA 103 
IL-8 TGCAGTTTTGCCAAGGAGTG TGATAAATTTGGGGTGGAAAGG 83 
TNFα CAATGGCGTGGAGCTGAGAG TCTGGTAGGAGACGGCGATG 152 
 
3.15 Protein extraction and quantification 
2DD cells were grown in 10 cm diameter plates under the previously described treatment 
conditions (3.8.1, 3.8.2 and 3.8.3). At the end of the incubation period, cells were dissociated from 
the surface of culture plates using TrypLE Express (Life Technologies) and centrifuged at 200 x g 
for 5 min to pellet cells. Supernatant was removed followed by cell re-suspention in RIPA buffer 
(150 mM NaCl, 25 mM Tris-HCl pH 7.6, 1.0% w/v sodium deoxycholate, 1 mM EDTA pH 8.0 
and 1.0% v/v NP-40) or Laemmli lysis buffer (62.5 mM Tris-HCl pH 6.8, 2% w:v SDS, 10% v/v 
glycerol and 5% v/v 2-mercaptoethanol) containing Protease Inhibitor Cocktail 2 (Sigma-Aldrich, 
Cat #: P8340) and Phosphatase Inhibitor Cocktail 2 (Sigma-Aldrich, Cat #: P5726) at a ratio of 
100:1:1. Samples were incubated on ice for 30 min with intermittent vortexing. All protein extracts 
were stored at -20°C until analyses. 
If RIPA buffer was used for protein extraction, protein extracts were quantified by 
Bradford assay using Bio-Rad Protein Assay Dye Reagent Concentrate (Bio-Rad Laboratories, 
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Mississauga, ON, Cat #: 500-0006). Briefly, Dye Reagent Concentrate was diluted 1:5 with Milli-
Q™ water. For each sample, 2 µL cell lysate was diluted in 18 µL Milli-Q™ water and then added 
into 1.0 mL diluted Bio-Rad dye reagent. Following incubation at room temperature for 15 minutes, 
absorbance was read at 595 nm. BSA was used as a standard at the concentrations of 0.2, 0.4, 0.6, 
0.8 mg/mL diluted in Milli-Q™ water. The absorbance of 1 mL diluted dye reagent containing 
different BSA concentrations was obtained and a standard curve was plotted. The blank consisted 
of 20 µL of Milli-Q™ water and 1 mL diluted dye reagent. The concentration of each protein 
extract was calculated against the standard curve. 
If Laemmli lysis buffer was used for protein extraction, protein extracts were quantified by 
UV spectroscopy using a NanoDrop™ 2000 Spectrophotometer. 1.5 µL cell lysate was loaded and 
protein concentration was measured at 280 nm. Laemmli lysis buffer (1.5 µL) was used as the 
blank.  
 
3.16 Western blot 
All protein samples were diluted to final concentrations of 1.0 or 1.5 µg/µL. For protein 
extracts prepared in RIPA buffer, samples were diluted in RIPA buffer and SDS-PAGE Loading 
Buffer (5X: 250 mM Tris-HCl pH 6.8, 30% v/v glycerol, 0.02% w/v bromophenol blue, 20% w/v 
2-mercaptoethanol and 10% w/v SDS). For protein extracts prepared in Laemmli lysis buffer, 
samples were diluted in 1X Laemmli lysis buffer and 1 µL of 1% bromophenol (w:v) blue was 
added to each sample. All diluted protein extracts were denatured by boiling at 95°C for 5 min and 
then cooled on ice. Samples were then centrifuged for 10 min at 15,000 rpm, and the supernatants 
were transferred to new labelled tubes and stored at -20°C until analyses.   
Denatured protein samples (15 to 30 µg cell lysate per sample) were loaded and separated 
on a polyacrylamide gel with a 5.0% polyacrylamide stacking top gel and a resolving bottom gel 
in 1X running buffer (25 mM Tris base, 192 mM glycine and 0.1% SDS) at 125 V. Proteins were 
then transferred to a nitrocellulose membrane (Bio-Rad Laboratories, Cat #: 1620115) in 1X 
transfer buffer (25 mM Tris base, 192 mM glycine and 20% methanol) using Trans-Blot® SD semi-
dry transfer cell (Bio-Rad Laboratories) at 25 V. The membranes were then blocked in 5.0% skim 
milk powder in phosphate-buffered saline with 0.05% Tween® 20 (PBST) for 1 h at room 
temperature, followed by incubating overnight at 4°C in primary antibody diluted in 5.0% skim 
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milk powder in PBST. Primary antibodies used were rabbit anti-phospho-NF-κB p65 (Ser536) 
antibody (1:1000 dilution; Cell Signaling Technology, Danvers, MA, USA, Cat #: 3033), mouse 
anti-SIRT1 antibody (1:1000 dilution; Abcam, Cat #: ab110304), mouse anti-phospho-mTOR (Ser 
2448) antibody (1:500 dilution; Santa Cruz, Dallas, TX, USA, Cat #: sc-293133), rabbit anti-LC3II 
(1:1000 dilution; Abcam, Cat #: ab48394), mouse anti-heme oxygenase 1 antibody (1:500 dilution; 
Santa Cruz, Cat #: sc-136960) mouse anti p-Histone H2A.X (Ser 139) antibody (1:500 dilution; 
Santa Cruz, Cat #: sc-517348) and rabbit anti-β-actin (1:2000 dilution; Abcam, Cat #: ab8227). 
Following primary antibody incubation, membranes were washed three times in 5.0% skim 
milk/PBST for 10 min. Membranes were then incubated in secondary antibody diluted in 5.0% 
skim milk/PBST for 1 h at room temperature. Secondary antibodies used were goat anti-rabbit 
horse radish peroxidase (HRP) (1:2000 dilution; Abcam, Cat #: ab97069) or donkey anti-mouse 
HRP (1:2000 dilution, Jackson Scientific, West Grove, PA, USA, Cat #: 715-035-150). 
Membranes were then washed two times in 5.0% skim milk/PBST for 10 min each and two times 
in PBST for 5 min. Protein bands were visualized with chemiluminescence using enhanced 
chemiluminescence (ECL) reagent (100 mM Tris-HCl pH 8.5, 0.2 mM p-coumaric acid, 1.25 mM 
3-aminophtalhydrazide and 0.1% v/v H2O2). β-actin was used as a loading control.  
 
3.17 Chromatin immunoprecipitation-qPCR (ChIP-qPCR) 
2DD cells were grown in 15 cm diameter plates and treated with DMSO (control) or 100 
µM Avn C for 48 h. At the end of the treatment period, cells were fixed with 1% paraformaldehyde 
(Electron Microscopy Sciences, Hatfield, PA, USA, Cat #: 15714) in 15 mL serum-free culture 
media per plate for 10 min at room temperature. Fixation was terminated by adding glycine into 
culture media to a final concentration of 125 mM followed by incubation at room temperature for 
10 min. Media was then removed and cells were washed two times with ice-cold PBS. Cells were 
scraped in ice-cold PBS and centrifuged at 200 rcf for 5 min at 4°C to pellet cells. Cells were then 
re-suspended in 400 µL ChIP lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl pH 8.0) 
containing Protease Inhibitor Cocktail 2 (Sigma-Aldrich, Cat #: P8340) and Phosphatase Inhibitor 
Cocktail 2 (Sigma-Aldrich, Cat #: P5726). Following 10 min of incubation on ice, cells were 
sonicated on ice at ~7% power output and 30% duty cycle for 1 min. Samples were then 
centrifuged at 12,000 rcf 4°C for 10 min and supernatants were transferred to new 1.5 mL tubes 
as sheared chromatin samples. Aliquots of chromatin samples were stored at -80°C until analyses.  
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From each treatment condition, 30 µL of the chromatin sample was used as the input 
sample and 60 µL of the chromatin sample was used for each immunoprecipitation. A 2.5 µg 
aliquot of mouse anti-Nrf2 antibody or 2.5 µg of rabbit anti-phospho-NF-κB p65 (Ser536) 
antibody was added to 60 µL chromatin sample diluted 10 times in ChIP buffer (0.01% SDS, 1.1% 
Triton X100, 1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.0 and 167 mM NaCl) containing Protease 
Inhibitor Cocktail 2 (Sigma-Aldrich, #: P8340) and Phosphatase Inhibitor Cocktail 2 (Sigma-
Aldrich, Cat #: P5726). 2.5 µg donkey anti-mouse HRP was used as the non-specific antibody 
control. The mixture was incubated at 4°C overnight with rotation, followed by binding to 50 µL 
Dynabeads™ Protein A (Life Technologies, Oslo, Norway, Cat #: 10006D) at 4°C for 1 h. The 
samples were then washed three times with ChIP washing buffer I (0.1% SDS, 1% Triton X100, 
2 mM EDTA, 20 mM Tris pH 8.0 and 150 mM NaCl) for 5 min each, three times with ChIP 
washing buffer II (0.1% SDS, 1% Triton X100, 2 mM EDTA, 20 mM Tris pH 8.0 and 500 mM 
NaCl) for 5 min each and three times with ChIP washing buffer III (1 mM EDTA and 10 mM Tris-
HCl pH 8.0) for 5 min each. After washing steps, samples were eluted with 500 µL freshly made 
elution buffer (1% SDS and 0.1 M NaHCO3) for 1 h at room temperature. For each eluted and 
input sample, crosslinks were reversed by adding 200 mM NaCl, 12.5 mM EDTA and 2 µL 
proteinase K (Invitrogen, Cat #: 25530049), followed by incubation at 65°C for 5 h with agitation 
at 900 rpm in a thermal mixer. The DNA from each sample was extracted by phenol-chloroform 
as follows: after reverse-crosslinking, 500 µL of phenol-chloroform (1:1, pH 8.0) was added into 
each tube and vigorously vortexed.  Samples were then centrifuged at 12,000 rcf for 10 min at 4°C. 
The clear upper-phase was separated from the sample and placed in a new 1.5 mL centrifuge tube. 
DNA was precipitated by adding 2.0 µL glycogen and 1X sample volume of isopropanol. Samples 
were then centrifuged at 12,000 rcf for 30 min at 4 °C, and the supernatant was removed. The 
DNA pellet from the input sample was re-suspended in 40 µL nuclease-free water and DNA from 
immunoprecipitated sample was re-suspended in 80 µL nuclease-free water. Chromatin shearing 
efficiency was checked monitored by running 5 µL input DNA samples on a 1.5% agarose gel and 
most DNA fragments were found between 200 and 1000 bp on the gel. A representative gel picture 
is shown in Figure 3.2 that indicates sheared DNA fragment sizes after sonication.  
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Figure 3.2 Gel electrophoresis of sheared DNA samples for ChIP assay 
 
qPCR was performed following DNA extraction. Ten microliter reactions were set up using 
5 μL PerfeCTa® SYBR® Green SuperMix for iQ (Quantabio, Beverly, MA, USA, Cat #: 95053-
500), 1 μL ChIP DNA sample, 3 μL H2O and 1 μL of 3 μM forward and reverse ChIP primers. 
qPCR reactions were conducted using a Rotor-Gene® Q qPCR (Qiagen, Foster City, CA, USA). 
All reactions for each gene were run in triplicate with non-template controls. ChIP-qPCR data was 
normalized by the percent input method. Standard error was calculated as a function of the standard 
deviations of triplicates. ChIP-qPCR primers used are listed in Table 3.2. 
 
Table 3.3 ChIP-qPCR primers 
Gene 
Forward primer 
(5’→3’) 
Reverse primer 
(5’→3’) 
Amplicon 
(bp) 
HMOX1 CCGCCCCGAGATCTGTTTTC ATGTCCCGACTCCAGACTCC 157 
NQO1 TGAGAGTCCTGGGGAGACAT CACCCAGGGAAGTGTGTTGT 103 
IL-1β TTGCCCTTCCATGAACCAGAG AAGCAGAAGTAGGAGGCTGAGA 147 
IL-8 GTGATGACTCAGGTTTGCCCT CTTATGGAGTGCTCCGGTGG 139 
 
3.18 Statistical analysis  
Results were presented as mean ± standard deviation of three biological replicates. Two-
tailed Student's t test or one-way ANOVA with Tukey’s HSD (honest significant difference) was 
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performed to assess statistical significance between groups as indicated in the legends. p‐values 
<0.05 were considered statistically significant. 
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4.0 RESULTS 
4.1 Identification and quantitative analysis of Avn A, B & C in oat seeds by HPLC-PDA  
To identify the presence and concentrations of Avn A, Avn B and Avn C, methanol extracts 
of oat seeds from ten oat varieties and breeding lines were analyzed by HPLC-PDA. Avn A, B and 
C in oat extracts were identified based on their retention times and UV-visible spectral profiles 
compared with pure standards (Figure 4.1). Figure 4.2 shows a representative HPLC 
chromatogram of the oat extract from CDC Dancer. The three peaks labeled 1, 2 and 3 in the 
chromatogram were identified as Avn C, Avn A and Avn B. All ten oat extracts showed these 
peaks clearly, which indicates that Avn A, B and C can be successfully extracted using the methods 
described above (3.2 and 3.3). 
Concentrations of Avn A, B and C in oat extracts were determined by comparing the peak 
area of the identified Avn A, B and C in the sample with standard curves from the three standards 
(concentration vs. peak area). As shown in Table 4.1, the concentrations of Avn A, B and C present 
in the ten oat samples ranged from 1.8 to 21.4, 2.2 to 34.7 and 4.4 to 34.5 mg/kg, respectively, and 
the total amount of Avn A, B and C in the ten oat extracts ranged from 8.4 to 90.6 mg/kg. Among 
the ten samples, BW10 not only contained the highest total amount of the three avenanthramides 
(90.6 ± 2.3 mg/kg), it also showed the highest concentrations of individual Avn A (21.4 ± 0.7 
mg/kg), Avn B (34.7 ± 0.9 mg/kg) and Avn C (34.5 ± 0.9 mg/kg). In contrast, CDC Sol-Fi 
contained the lowest total Avns (A+B+C) of 8.4 ± 0.3 mg/kg, which was ~11 times less than that 
observed in BW10. It also showed the lowest concentrations of individual Avn A (1.7 ± 0.1 
mg/kg), Avn B (2.2 ± 0.1 mg/kg) and Avn C (4.4 ± 0.2 mg/kg).  
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Figure 4.1 HPLC-PDA chromatogram (A) and UV-visible spectral profiles (B) of Avn A, B and 
C standards (10 ppm) monitored at 340 nm. 
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Figure 4.2 HPLC-PDA chromatogram of the oat extract from the CDC Dancer variety monitored 
at 340 nm.  Peak assignments: 1. Avn C; 2. Avn A; 3. Avn B 
 
Table 4.1 Concentrations (mg/kg) of individual and total Avn A, B and C in oat seeds of ten 
varieties and breeding lines. 
Variety Avn A Avn B Avn C Total 
BW10 21.4 ± 0.7a 34.7 ± 0.9a 34.5 ± 0.9a 90.6 ± 2.3a 
BW513 5.4 ± 0.2b 9.3 ± 0.1b 11.0 ± 0.1b 25.8 ± 0.3b 
BW5303 3.8 ± 0.1c 4.4 ± 0.1c 6.6 ± 0.1c 14.8 ± 0.1c 
CDC Dancer 19.1 ± 0.2d 19.6 ± 0.3d 19.0 ± 0.2d 57.6 ± 0.2d 
CDC Morrison 8.0 ± 0.3e 11.4 ± 0.4e 10.3 ± 0.2e 29.6 ± 0.9e 
CDC Sol-Fi 1.8 ± 0.1f 2.2 ± 0.1f 4.4 ± 0.2f 8.4 ± 0.3f 
Jumbo 3.9 ± 0.3c 4.3 ± 0.1c 4.5 ± 0.1fg 12.7 ± 0.5g 
Marion 2.2 ± 0.2g 3.1 ± 0.2g 4.8 ± 0.1g 10.0 ± 0.5h 
Newburg 2.8 ± 0.2h 4.8 ± 0.1h 5.5 ± 0.1h 13.1 ± 0.3g 
OT2021 9.8 ± 0.2i 12.6 ± 0.3i 11.5 ± 0.2i 33.9 ± 0.6i 
Note: Values represent mean ± standard deviation of three replicates. Values in the same column 
followed by a common letter were not statistically different (p<0.05; ANOVA/Tukey) between 
varieties. 
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4.2 Total phenolic content and antioxidant activities of oat phenolic-rich extracts 
4.2.1 Total phenolic content determined by the Folin-Ciocalteau assay 
Total phenolic content of oat extracts from the ten oat varieties and breeding lines were 
determined by Folin-Ciocalteu (FC) method, which measures the absorption reduction of a 
phosphomolybdic-phosphotungstic acid reagent (FCR) to a blue-colored complex under alkaline 
conditions in the presence of phenolics. Under basic conditions, dissociation of a phenolic proton 
leads to a phenolate anion, which is capable of reducing FCR (Singleton et al., 1999). Gallic acid 
was used as a standard and results were reported as gallic acid equivalent (GAE) per 100 g oat 
powder. As shown in Table 4.2, total phenolic content of the ten oat extracts ranged from 78.5 ± 
0.7 to 121.2 ± 2.5 GAE/100 g. The highest total phenolic content was found in BW10 (121.2 ± 2.5 
GAE/100 g), followed by OT 2021 (102.5 ± 2.0 GAE/100 g) and BW5303 (97.9 ± 1.1 GAE/100 
g), and the lowest was found in the Newburg variety (78.5 ± 0.7 GAE/100 g).  
 
Table 4.2 Total phenolic content of ten oat phenolic extracts from different varieties as determined 
by the Folin-Ciocalteau assay 
Variety Total phenolic content (mg GAE/100 g oat) 
BW 10 121.2 ± 2.5a 
BW 513 87.7 ± 1.2b 
BW 5303 97.9 ± 1.1c 
CDC Dancer 86.8 ± 1.5bd 
CDC Morrison 84.5 ± 1.3de 
CDC Sol-Fi 82.3 ± 1.4e 
Jumbo 89.7 ± 1.5b 
Marion 89.2 ± 1.4b 
Newburg 78.5 ± 0.7f 
OT 2021 102.5 ± 2.0g 
Note: Values represent mean ± standard deviation of three replicates. Values followed by a 
common letter were not statistically different (p<0.05; ANOVA/Tukey) between varieties. GAE: 
gallic acid equivalent. 
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4.2.2 ABTS & DPPH radical scavenging activity 
ABTS and DPPH free radical systems were used to determine free the radical scavenging 
activity of ten oat extracts. Both assays measure the reduction in colour of the synthetic free radical 
solutions caused by electron transfer from antioxidants (Huang et al. 2005; Sharma and Singh, 
2013). Specifically, the ABTS assay is based on the generation of a blue/green ABTS•+ radical 
cation that can be reduced by antioxidants; whereas the DPPH assay is based on the reduction of 
the purple DPPH• radical to 1,1-diphenyl-2-picryl hydrazine in the presence of antioxidants 
(Huang et al. 2005; Sharma and Singh, 2013). By measuring the changes of colour intensity in the 
sample solution, free radical scavenging activities of oat extracts were determined. Results are 
presented as concentrations (g oat/mL) required to inhibit 50% of the free radicals in solution 
(IC50) (Table 4.3). A low IC50 value represents a higher free radical scavenging activity. The 
highest ABTS free radical scavenging activity was found in BW10 with an IC50 value of 0.87 ± 
0.02 g oat/mL, whereas the lowest ABTS free radical scavenging activities were found in BW513 
and Newburg with an equal IC50 value of 1.38 ± 0.01 g oat/mL. The highest DPPH free radical 
scavenging activity was found in OT2021 with an IC50 value of 0.279 ± 0.007 g oat/mL, whereas 
the lowest DPPH free radical scavenging activity was found in Newburg with an IC50 value of 
0.798 ± 0.049 g oat/mL. 
Table 4.3 ABTS and DPPH free radical scavenging activities of ten oat phenolic extracts from 
different varieties. 
Variety ABTS IC50 DPPH IC50 
BW 10 0.87 ± 0.02a 0.29 ± 0.00a 
BW 513 1.38 ± 0.01b 0.38 ± 0.01b 
BW 5303 1.16 ± 0.02c 0.37 ± 0.01b 
CDC Dancer 1.03 ± 0.04df 0.35 ± 0.02b 
CDC Morrison 1.06 ± 0.03d 0.36 ± 0.01b 
CDC Sol-Fi 1.26 ± 0.03e 0.38 ± 0.01b 
Jumbo 1.25 ± 0.02e 0.46 ± 0.01c 
Marion 1.21 ± 0.05ce 0.41 ± 0.00d 
Newburg 1.38 ± 0.01b 0.80 ± 0.05e 
OT 2021 0.99 ± 0.02f 0.28 ± 0.01f 
Note: Values represent mean ± standard deviation of three replicates. Values in the same column 
followed by a common letter were not statistically different (p<0.05; ANOVA/Tukey) between 
varieties. IC50: concentration (g oat/mL) required for 50% free radical inhibition. 
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4.3 ABTS & DPPH radical scavenging activity of Avn A, B & C 
Free radical scavenging activities of pure Avn A, B and C were determined by the same 
ABTS and DPPH free radical assays used for the oat extracts (4.2.2). Gallic acid, caffeic acid and 
Trolox were used as references for comparison. The concentrations required to inhibit 50% of the 
free radicals in solution (IC50) are presented in Table 4.4. From these results, the order of free 
radical scavenging activity in the ABTS assay was, gallic acid > Avn C = Avn B > Trolox = caffeic 
acid = Avn A, whereas in the DPPH assay the order of free radical scavenging activity was gallic 
acid > Avn C > caffeic acid > Trolox > Avn B > Avn A. Collectively, Avn C not only showed the 
highest antioxidant activity among the three avenanthramides, but also showed a higher 
antioxidant activity than caffeic acid and Trolox, which are commonly considered as strong 
antioxidants.  
 
Table 4.4 ABTS and DPPH free radical scavenging activities of Avn A, B and C as compared to 
Caffeic acid, Gallic acid and Trolox 
 ABTS IC50 DPPH IC50 
Avn A 1.20 ± 0.01a 1.26 ± 0.03a 
Avn B 0.84 ± 0.02b 0.61 ± 0.01b 
Avn C 0.82 ± 0.02b 0.41 ± 0.01c 
Caffeic acid 1.19 ± 0.02a 0.45 ± 0.03d 
Gallic acid 0.37 ± 0.01c 0.14 ± 0.01e 
Trolox 1.18 ± 0.01a 0.54 ± 0.02f 
Note: Values represent mean ± standard deviation of three replicates. Values in the same column 
followed by a common letter were not statistically different (p<0.05; ANOVA/Tukey) between 
different compounds. IC50: concentration (mM) required for 50% free radical inhibition. 
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4.4 Avn C protects normal human skin fibroblasts from H2O2-induced cellular damage 
4.4.1 Avn C protects 2DD fibroblasts from H2O2-induced oxidative stress 
Results from the ABTS and DPPH free radical scavenging assays demonstrated that Avn 
C had promising antioxidant potential; however, it is unclear how well this phenolic compound 
penetrates cell membranes and is able to scavenge free radicals in normal human cells. To evaluate 
cytoprotective effects of Avn C against H2O2-induced oxidative stress, normal human fibroblasts 
(2DD) were used as a cell culture model. 2DD cells were pre-treated with Avn C for 48 hours prior 
to 1 h exposure to H2O2 to induce oxidative stress. Free radicals inside cells were stained with a 
reduced, non-fluorescent dye MitoTracker Orange that becomes fluorescent when oxidized by free 
radicals. Fluorescence micrographs were collected and the intensity of the Mitotracker™ dye was 
examined. Figure 4.3 illustrates representative cell images stained with MitoTracker Orange 
(orange) for labeling free radicals and DAPI (blue) for labeling cell nuclei? Control cells (DMSO 
only) showed a small amount of orange fluorescent signal (Figure 4.3 A) and a dramatic increase 
of the signal was observed in the cells with H2O2 treatment alone (Figure 4.3 B). Pre-treatment 
with 100 and 200 μM Avn C for 48 h before H2O2 treatment showed decreased orange fluorescent 
signals (Figure 4.3 C&D) when compared with H2O2 treatment alone, indicating that Avn C 
penetrated into cells and was capable of scavenging intracellular free radicals. 
To further evaluate the protective capacity of Avn C against H2O2-induced oxidative stress, 
we examined transcript levels of antioxidant genes normally stimulated by oxidative stress. After 
pre-treatment with Avn C for 48 h followed by 1 h H2O2 exposure, total RNA was extracted, 
converted to cDNA and evaluated by qRT-PCR. Hydrogen peroxide treatment without cell pre-
treatment with Avn C resulted in a significant increase in the transcripts from the GSS, HMOX1, 
SOD1, GPx1 and CAT genes (Figure 4.4). By comparison with H2O2 treatment alone, pre-
treatment of 2DD cells with 200 M Avn C significantly suppressed increased levels of all the 
transcripts induced by H2O2. Also, pre-treatment with 100 M Avn C significantly suppressed 
increased levels of all the transcripts with the exception of CAT.  
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A. Control (DMSO)                                                 B. DMSO + H2O2 
 
    
C. 100 μM Avn C + H2O2                                   D. 200 μM Avn C + H2O2 
 
Figure 4.3 Avn C reduces H2O2-induced intracellular free radicals in 2DD fibroblasts. 2DD 
primary dermal fibroblasts growing on coverslips were pre-treated with DMSO (control) or Avn 
C (100 μM and 200 μM; 48h) prior to 1 h exposure to 200 μM H2O2. Following the treatments, 
cells were washed and incubated with MitoTracker™ Orange dye, fixed and mounted for 
fluorescence microscopy. MitoTracker™ Orange dye reacts with free radicals inside cells to 
generate orange fluorescence. Cell chromatin is counterstained with DAPI (blue) to indicate 
nuclear location. Scale bar - 50 μm. 
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Figure 4.4 Avn C suppresses H2O2-induced mRNA expression of antioxidant enzymes. 2DD 
primary fibroblasts were pre-treated with DMSO (0) or Avn C (100 μM and 200 μM) for 48 h 
prior to exposure to 200 μM H2O2. qRT-PCR on cDNA libraries was performed for glutathione 
synthetase (GSS), heme oxygenase 1 (HMOX1), superoxide dismutase 1 (SOD1), glutathione 
superoxidase 1 (GPx1) and catalase (CAT) gene transcripts. Graphs indicate the average fold 
change from three biological replicates. Error bars represent the standard deviations. *p-value 
<0.05, **p-value <0.01 vs H2O2 treatment alone 
 
4.4.2 Avn C protects 2DD fibroblasts from H2O2-induced DNA damage 
One of the major biological consequences of free radical production and exposure is 
increased DNA damage. Upon DNA damage, the histone variant H2AX- becomes 
phosphorylated (p-H2AX) and is deposited at the sites of damage, facilitating the recruitment of 
repair machinery; therefore, p-H2AX is commonly used as a sensitive marker for DNA double-
strand breaks. We evaluated the ability of Avn C to protect cells from H2O2-induced DNA damage 
by measuring p-H2AX expression. After pre-treatment of normal human skin fibroblasts (2DD) 
with Avn C for 48 h followed by 1 h H2O2 exposure, a whole cell extract was obtained and 
subjected to western blot analysis. We observed that pre-treatment with Avn C (100 M and 200 
M) significantly decreased levels of p-H2AX (as determined by γ-H2AX to β-actin ratios) 
induced by H2O2 (Figure 4.5), further demonstrating the cytoprotective effects of Avn C on normal 
cells. 
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Figure 4.5 Avn C suppresses H2O2-induced DNA double-strand breaks. Normal human skin 
fibroblasts (2DD) were pre-treated with DMSO (0) or Avn C (100 μM and 200 μM) for 48 h 
followed by 1 h exposure to 200 μM H2O2. Whole cell extract was then obtained and subjected to 
western blot analysis. Data are presented as a ratio of γ-H2AX to β-actin. Representative blot 
images are shown. All graphs indicate mean values from three biological replicates. Error bars 
represent standard deviations. *p-value <0.05, **p-value <0.01 vs H2O2 treatment alone. 
 
4.4.3 Avn C protects 2DD fibroblasts from H2O2-induced inflammatory responses 
Free radicals inside cells not only promote oxidative stress, they also increase inflammatory 
response (Mittal et al., 2014; Morgan and Liu, 2011). As we observed that Avn C showed a 
cytoprotective effect against H2O2-induced oxidative stress in 2DD fibroblasts, we evaluated if 
Avn C could also reduce H2O2-induced inflammation in 2DD cells. We first measured the ability 
of Avn C to suppress the transcript levels of pro-inflammatory markers following H2O2 treatment. 
Transcripts from Il-1β, Il-6, Il-8 and TNF-α genes were evaluated by qRT-PCR. Avn C 
significantly reduced the amounts of transcripts from Il-6, Il-8 and TNF-α under pre-treatment 
conditions of 100 and 200 μM Avn C, whereas a significant reduction of Il-1β was only observed 
at the 200 μM pre-treatment concentration (Figure 4.6 A).  
Evidence has shown that oxidative damage to cells leads to the release of TNF-𝛼 from 
these damaged cells (Kim et al., 2008). Binding of TNF-𝛼 to cell receptors activates NF-𝜅B, a 
dimer of p65 (RelA) and p50 proteins, which results in the further generation of proinflammatory 
cytokines (Kim et al., 2008). As we observed that Avn C suppressed H2O2-induced pro-
inflammatory cytokine transcripts, we further evaluated if this suppression effect was mediated by 
inhibition of NF-κB activation in 2DD fibroblasts. Western blot analyses of phosphorylated NF-
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𝜅B p65 (Ser536) demonstrated that H2O2 treatment alone resulted in an increased protein level of 
phosphorylated p65, which was significantly reduced by 100 and 200 μM Avn C pre-treatment 
(Figure 4.6 B). These observations indicate that Avn C is able to protect normal human skin 
fibroblasts against H2O2-induced inflammation through both the suppression of increased levels 
of pro-inflammatory cytokine transcription and NF-𝜅B activation. 
 
 
 
Figure 4.6 Avn C suppresses H2O2-induced mRNA expression of pro-inflammatory 
cytokines and NF-κB activation in 2DD fibroblasts. Normal human skin fibroblasts (2DD) were 
pre-treated with DMSO (0) or Avn C (100 μM and 200 μM) for 48 h followed by 1 h exposure to 
200 μM H2O2. A) RT-qPCR on cDNA libraries was performed for interlukin-1 beta (IL-1β), 
interlukin-6 (IL-6), interlukin-8 (IL-8) and tumor necrosis factor (TNF) gene transcripts. Data are 
represented as the fold change against control. B) Western blot analysis of phospho-NF-𝜅B p65 
(Ser536) (p-p65) expression. Data are presented as a ratio of p-p65 to β-actin. Representative blot 
images are shown. All graphs indicate mean values from three biological replicates. Error bars 
represent standard deviations. **p-value <0.01 vs H2O2 treatment alone. 
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4.5 Anti-inflammatory potential of Avn C 
4.5.1 Avn C protects 2DD fibroblasts from TNFα-induced inflammation 
As we observed a protective effect of Avn C against oxidative stress-induced inflammatory 
response in 2DD fibroblasts, we investigated if the suppression effect of inflammation could be 
independent from Avn C free radical scavenging ability. Many proteins and signaling molecules 
can induce a significant stress to activate pro-inflammatory markers. One such molecule is TNF-
α, which can either function as an autocrine or paracrine stimulator and triggers signaling events, 
leading to NF-𝜅B activation in different cell types. Hence, we evaluated if Avn C also could protect 
2DD fibroblasts against TNFα-induced inflammation. RT-qPCR results demonstrated that TNF-α 
treatment alone strongly increased the level of transcripts from the Il-1β, Il-8 and TNF-α genes 
(Figure 4.7 A). Pre-treatment with Avn C at 100 and 200 μM significantly reduced the mRNA 
levels of Il-1β, Il-8 and TNF-α induced by TNF-α treatment. Western blot analyses of 
phosphorylated NF-𝜅B p65 (Ser536) demonstrated that TNF-α treatment alone resulted in an 
increased protein level of phosphorylated p65, which was significantly reduced by 100 and 200 
μM Avn C pre-treatment (Figure 4.7 B). 
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Figure 4.7 Avn C suppresses TNF-α-induced mRNA expression of pro-inflammatory 
cytokines and NF-κB activation in 2DD fibroblasts. Normal human skin fibroblasts (2DD) were 
pre-treated with DMSO (0) or Avn C (100 μM and 200 μM) for 24 h followed by 4 hours exposure 
to 10 ng/mL TNF-α. A) RT-qPCR on cDNA libraries was performed for interlukin-1 beta (IL-1β), 
interlukin-6 (IL-6), interlukin-8 (IL-8) and tumor necrosis factor alpha (TNF) gene transcripts. 
Data are represented as the fold change against control. B) Western blot analysis of phospho-NF-
𝜅B p65 (Ser536) (p-p65) expression. Data are presented as a ratio of p-p65 to β-actin. 
Representative blot images are shown. All graphs indicate mean values from three biological 
replicates. Error bars represent standard deviations. * p-value <0.05, ** p-value <0.01 vs TNF-α 
treatment alone. 
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4.5.2 Avn C reduces basal inflammation through NF-κB inhibition in 2DD fibroblasts 
It has been reported and verified by several studies that constitutive low-grade 
inflammation is tightly associated with the aging process, as supported by NF-κB system activation 
in various tissues during aging (Spencer et al., 1997; Kim et al., 2002; Kim et al.,2006). As we 
observed that Avn C showed a cytoprotective effect against H2O2-induced and TNFα-induced 
inflammation, we further investigated if Avn C could also exert its anti-inflammatory activity 
under normal metabolic conditions inside cells. Following Avn C treatment for 48 h on 2DD 
fibroblasts, RNA was extracted, converted to cDNA and evaluated by RT-qPCR. mRNA fold 
changes of pro-inflammatory cytokines are shown in Figure 4.8 A. These results demonstrated a 
significant reduction of Il-1β, Il-8, IL-6 and TNF-α transcripts at the basal level, except for TNF-α 
at 100 μM Avn C treatment. Western blot analyses were performed on cell protein extracts under 
the same treatment conditions. It was found that 100 and 200 M Avn C treatment significantly 
increased protein expression of phosphorylated NF-𝜅B p65 (Ser536) in 2DD fibroblasts (Figure 
4.8 B).  
To further confirm that Avn C reduced inflammatory response by inhibiting NF-κB 
activation, chromatin immunoprecipitation-qPCR (ChIP- qPCR) was performed to analyze 
changes in NF-κB binding activity to promoter regions of Il-1β and Il-8 with 48 h of 100 M Avn 
C treatment. We observed that 100 μM Avn C treatment significantly decreased NF-κB binding 
activity to both Il-1β and Il-8 promoter regions (Figure 4.8 C), indicating that NF-κB activity was 
down-regulated. Taken together, these findings suggest that Avn C reduces basal inflammation 
through reduced NF-κB activation in 2DD fibroblasts. 
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Figure 4.8 Avn C reduces pro-inflammatory cytokine transcriptions through decreased DNA 
binding activity of NF-κB in 2DD fibroblasts. A) 2DD human skin fibroblasts were treated with 
DMSO (control) or Avn C (100 μM and 200 μM) for 48 h. RT-qPCR on cDNA libraries was 
performed for interlukin-1 beta (IL-1β), interlukin-6 (IL-6), interlukin-8 (IL-8) and tumor necrosis 
factor (TNF) gene transcripts. Data are represented as the fold change against control. B) Western 
blot analysis of phospho-NF-κB p65 (p-p65) expression in 2DD cells treated with DMSO (0) or 
Avn C (50 μM, 100 μM and 200 μM) for 48 h. Data are presented as a ratio of p-p65 to β-actin. 
Representative blot images are shown.  C) ChIP-qPCR analysis of phospho-NF-κB p65 binding 
activity to promoter regions of interlukin-1 beta (IL-1β) and interlukin-8 (IL-8) in 2DD cells 
treated with control (DMSO) or 100 μM Avn C for 48 h. Data are represented as the enrichment 
relative to % input. All graphs indicate mean values from three biological replicates. Error bars 
represent standard deviations. *p-value<0.05, **p-value <0.01 vs control. 
  
52 
 
4.6 Avn C induces HO-1 expression through Nrf2 activation in 2DD fibroblasts 
Given that Avn C showed a cytoprotective effect against H2O2-induced oxidative stress 
through free radical scavenging which decreased H2O2-induced antioxidant gene transcription, we 
further investigated if Avn C could also exert protective effects by activating other cytoprotective 
pathways independent of free radical scavenging. 2DD cells were treated with Avn C for 48 h and 
RNA was extracted, converted to cDNA and evaluated by RT-qPCR to examine if there was any 
antioxidant enzyme that was up-regulated by Avn C treatment. Transcript quantification by qPCR 
demonstrated that HMOX1 was significantly up-regulated by 50, 100 and 200 μM Avn C treatment 
(Figure 4.9 A), whereas other antioxidant genes either showed no significant change or significant 
decreases. To further confirm if HMOX1 gene expression was induced by Avn C treatment, 
western blot was used to analyze protein expression levels of HO-1, which is coded by the HMOX1 
gene. It was found that 100 and 200 μM Avn C treatment significantly increased protein expression 
of HO-1 in 2DD fibroblasts (Figure 4.9 B).  
Expression of HO-1 is regulated by nuclear factor-E2-related factor 2 (Nrf2) (Itoh et al., 
1997; Alam et al., 1999). To investigate the impact of Avn C treatment on Nrf2-DNA binding 
activity of, 2DD cells were treated with vehicle (DMSO) or 100 μM Avn C for 48 h. Cells were 
then cross-linked and chromatin immunoprecipitation-qPCR (ChIP- qPCR) was performed to 
analyze Nrf2 binding activity to promoter regions of HMOX1 and NAD(P)H quinone 
dehydrogenase 1 (NQO1) genes, which have been identified as Nrf2-regulated genes (Alam et al., 
2000; Nioi et al., 2003). Treatment of cells with 100 μM Avn C treatment significantly increased 
Nrf2 binding activity to both HMOX1 and NQO1 promoter regions (Figure 4.9 C). Taken together, 
these findings indicate that Avn C induced HO-1 expression through increased DNA binding 
activity of Nrf2 in 2DD fibroblasts. This indicates that Avn C not only reduces oxidative stress 
through scavenging free radicals, it could also mediate signaling pathways resulting in 
cytoprotection. 
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Figure 4.9 Avn C induces heme oxygense-1 expression through increased DNA binding 
activity of Nrf2 in 2DD fibroblasts. A) 2DD human skin fibroblasts were treated with DMSO 
(control) or Avn C (50 μM, 100 μM and 200 μM) for 48 h. qRT-PCR on cDNA libraries was 
performed for glutathione synthetase (GSS), heme oxygenase 1 (HMOX1), superoxide dismutase 
1 (SOD1), glutathione superoxidase 1 (GPx1) and catalase (CAT) gene transcripts. Data are 
represented as fold changes against control. B) Western blot analysis of heme oxygenese-1 (HO-
1) expression in 2DD cells treated with DMSO (control) or Avn C (100 μM and 200 μM) for 48 
h. Data are presented as a ratio of HO-1 to β-actin. Representative blot images are shown.  C) 
ChIP-qPCR analysis of Nrf2 binding activity to promoter regions of heme oxygenase 1 (HMOX1) 
and NAD(P)H quinone dehydrogenase 1 (NQO1) in 2DD cells treated with DMSO (control) or 
100 μM Avn C for 48 h. Data are represented as the enrichment relative to % input. All graphs 
indicate the average values from three biological replicates. Error bars represent the standard 
deviations.  *p-value<0.05, **p-value<0.01 vs control. 
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4.7 Anti-proliferative effect of Avn C 
4.7.1 Avn C reduces proliferative rate of 2DD fibroblasts through autophagy-independent 
pathway 
Results from this research showed that Avn C had a cytoprotective effect against oxidative 
and inflammatory stress, and also showed anti-aging potential through the activation of Nrf2 and 
inhibition of NF-κB activity. Studies have demonstrated that select phenolic compounds showed 
an anti-proliferative effect by activating the autophagy pathway, which promoted cellular health 
and increased longevity (Baur et al., 2006; Park et al., 2016; Holczer et al., 2018); therefore, we 
evaluated if Avn C could promote cellular health through similar mechanisms. To determine the 
anti-proliferative effect of Avn C on 2DD fibroblasts, we treated cells with either vehicle (DMSO) 
or 50, 100 and 200 μM Avn C for 48 h and monitored their growth. Avn C had a significant impact 
on proliferative rates in 2DD fibroblasts at 50, 100 and 200 μM concentrations (Figure 4.10 A). 
Trypan blue staining of cells indicated that there was no significant cell death in any of the 
treatment conditions used (Figure 4.10 B). To further confirm this response, we immuno-labeled 
Avn C treated 2DD fibroblasts for the proliferative marker Ki67, which is a nucleolar and 
chromatin-associated protein that is only present in actively dividing cells. 2DD cells showed a 
significant decreased in the number of Ki 67 positive cells at 50, 100 and 200 μM Avn C treatment 
(Figure 4.10 C). These observations indicated that Avn C was modulating cell growth in primary 
fibroblasts without causing cell death. 
As we observed a significantly decrease of proliferative rate with Avn C treated normal 
human fibroblast cells, we investigated if this anti-proliferative effect was caused by activation of 
the autophagy pathway. Western blot analyses were performed, and we observed no change in the 
levels of the autophagy marker protein light chain 3 isoform II (LC3-II) (Figure 4.11). Sirtuin 1 
(SIRT1) and mTOR are upstream molecules of autophagy activation and are responsible for 
sensing cellular energy levels. Western blot results also demonstrated that there was no change in 
SIRT1 and phospho-mTOR (activated mTOR) protein levels following 48 h Avn C treatment 
(Figure 4.10). To further confirm Avn C that does not activate the autophagy in normal human 
fibroblasts, a second normal human skin fibroblast cell line (FSF cells) was employed and showed 
the same western blot results as 2DD fibroblasts (Figure 4.11), indicating Avn C reduces the 
proliferative rate of normal human skin fibroblasts through an autophagy-independent pathway. 
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Figure 4.10 Avn C reduces proliferative rate of 2DD fibroblasts without inducing cell death. 
2DD fibroblasts were treated with DMSO (0) or Avn C (50 μM, 100 μM and 200 μM) for 48 h. A) 
Population doubling times. B) Trypan blue assays were conducted to detect percent (%) viable 
cells. C) Ki67 immuno-labelling of 2DD cells. Percent positive Ki67 cells was shown on the Y-
axis. All graphs indicate mean values from three biological replicates. Error bars represent standard 
deviations. *p-value<0.05, **p-value <0.01 vs control. 
 
 
Figure 4.11 Avn C does not induce autophagy in 2DD and FSF primary fibroblasts. Two 
primary fibroblasts (2DD and FSF) were treated with DMSO (0) or Avn C (100 μM and 200 μM) 
for 48 h. Whole cell lysates were extracted and subjected to western blot analysis for LC3-II, 
SIRT1 and phospho-mTOR (p-mTOR). β-actin was used as a loading control 
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4.7.2 Avn C reduces proliferative rates of breast cancer (MCF7) and bone cancer (U2OS) 
cells 
To determine if Avn C can inhibit the growth of cancer cells, several cancer cell lines, 
MCF7 (breast), HTC116 (colon), HepG2 (liver) and U2OS (bone) were used in this study. We 
treated the four cancer cells with vehicle (DMSO) or 50, 100 and 200 μM Avn C for 48 h followed 
by the determination of population doubling times. Both MCF7 and U2OS cells demonstrated an 
increase in population doubling times at 100 and 200 μM while HCT116 and HepG2 cells 
exhibited no change (Figure 4.12). Trypan blue staining of the four different cancer cells treated 
with Avn C indicated that there was no significant death observed at the concentrations used 
(Figure 4.12). These observations indicate that Avn C does not promote cell death and may not be 
effective at killing cancer cells but does have the potential to slow growth in MCF7 and U2OS 
cells at concentrations of 100 and 200 μM.  
 
 
Figure 4.12 Avn C reduces proliferative rates of breast cancer (MCF7) and bone cancer (U2OS) 
cells without inducing cellular death. MCF-7 cells (human breast adenocarcinoma), HCT 116 cells 
(human colon carcinoma), HepG2 cells (human liver hepatocellular carcinoma) and U2OS cells 
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(human bone osteosarcoma) were treated with DMSO (0) or Avn C (50 μM, 100 μM and 200 μM) 
for 48 h. A) Population doubling times of the four cancer cells treated with DMSO or Avn C for 
48h. B) Trypan blue assays were conducted to detect percent (%) viable cells for cancer cells 
treated with DMSO or Avn C for 48h. 
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5. DISCUSSION 
5.1 Overall discussion 
Oat consumption in the human diet has increased in the last decade due to growing interest 
in the health aspects of oats and oat containing products. Extensive research has focused on the 
high dietary fibre contents of oats, especially β-glucan, which was found to lower cholesterol levels 
and provide cardiovascular protection (Martínez-Villaluenga and Peñas, 2017). Recently, 
avenanthramides, a group of phenolic compounds found exclusively in oats, have received great 
interest and are considered as important contributors to the health benefits of oats. 
Avenanthramides are a group of phenolic compounds and structurally shown as amides with 
different hydroxycinnamic acids and different anthranilic acids (Collin, 1989). Since the discovery 
of this group of novel phenolic compounds in oats in 1989 (Collin, 1989), several studies have 
focused on chemically synthesizing avenanthramides and investigating in vitro antioxidant 
activities of Avn A, B and C, which are the three most abundant avenanthramides in oats (Dimberg 
et al., 1993; Peterson et al., 2002; Lee-Manion et al., 2009; Yang et al., 2014). Despite the use of 
different antioxidant activity assays, they all showed that Avn C had the highest in vitro antioxidant 
activity among the three. More recent research on the anti-inflammatory and anti-proliferative 
effects of Avn C or Avn C-enriched oat extracts employing different cell culture models has been 
conducted (Guo et al., 2008; Sur et al., 2008; Chu et al., 2013; Yang et al., 2014; Nie et al., 2006a; 
2006b). In addition, studies evaluating the bioavailability of Avns or oat phenolic-rich extracts in 
mice and humans found that they were bioavailable at nanomolar-level concentrations in plasma 
(Chen et al., 2004; Chen et al., 2007). Furthermore, it has been shown that Avn C was extensively 
metabolized by mice and the human microbiota to generate bioactive metabolites (Wang et al., 
2014). When taken together, this scientific evidence shows that Avn C is a compound of great 
research value with respect to its potential health benefits and mechanisms of action.  
Although several studies have shown that Avn C has significant free radical scavenging 
activity (Peterson et al., 2002; Bratt et al., 2003; Lee-Manion et al., 2009), no study has addressed 
the antioxidant efficacy of Avn C inside human cells. Additionally, current cellular studies on Avn 
C treatment has mostly focused on therapeutic effect instead of preventive effect. Furthermore, the 
mechanisms of Avn C that function as signaling mediators inside cells are still poorly understood. 
More importantly, the cytoprotective effect of a chemical compound is usually achieved by 
multiple mechanisms working together such as antioxidant, anti-inflammatory, antigenotoxic and 
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antiproliferation, through parallel or overlapping cellular pathways and results in an overall 
promoted cellular health; which has been found for resveratrol and EGCG (Aggarwal and 
Shishodia, 2006; Visioli et al., 2011; Zhang, 2015). Current research evidence on the 
cytoprotective effect of Avn C is mainly based on one or two effects in a specific cell line and 
lacks a comprehensive understanding of possible multiple functions/mechanisms. To investigate 
the cytoprotective potential of Avn C and better understand the mechanisms of action of Avns in 
oats, phenolic extracts from ten different oat varieties were produced and the Avns in these extracts 
were identified and quantified. In vitro radical-scavenging assays were used to confirm that Avn 
C had the highest antioxidant potential among the three Avns. In addition, multiple cytoprotective 
effects of Avn C on normal human skin cells were explored including antioxidant, antigenotoxicity, 
anti-inflammation and antiproliferation. Also, several potential molecular targets of Avn C that 
might attribute to its cytoprotective effects were investigated. Moreover, four cancer cell lines 
from different organs were employed for investigating the possible anticarcinogenesis effect of 
Avn C.   
In this research, Avn A, B and C in oat extracts were identified and quantified by HPLC-
PDA. Results showed that different oat vareties or lines had significant difference with regard to 
concentrations of Avn A, B & C, total phenolic content and free radical scavenging activity in oat 
extracts. In vitro radical-scavenging results showed that Avn C not only had the highest antioxidant 
activity among the three avenanthramides, it also showed higher antioxidant activity than caffeic 
acid and Trolox, which are commonly considered as strong antioxidants. From my cellular studies, 
I demonstrated for the first time that Avn C protected human skin fibroblasts from H2O2-induced 
cellular damage as shown by significantly reduced levels of intracellular free radicals, DNA 
damage and pro-inflammatory response. Pre-treatment of Avn C also protected cells against 
signaling to promote inflammatory responses induced by TNF-α, indicating its functional role as 
a signaling mediator other than free radical scavenger. Furthermore, mechanistic studies revealed 
that Avn C suppressed basal level of inflammation through decreased NF-κB DNA binding activity 
and induced heme oxygenase 1 expression through increased Nrf2 DNA binding activity, 
indicating that Avn C exerts antioxidant and anti-inflammatory effect, either or indirectly through 
modulating NF-κB and HO-1/Nrf2 signaling pathways apart from free radical scavenging. In 
addition, Avn C slowed the growth rate of normal human skin fibroblasts through autophagy-
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independent mechanisms. It also suppressed the growth of human breast cancer cells and bone 
cancer cells but did not induce cell death. 
 
5.2 Identification and quantification of Avn A, B and C in oat seeds from ten varieties and 
breeding lines 
Previous studies reported that Avn A, B and C are the most abundant avenanthramides in 
oats, whereas other identified avenanthramides have only been found in trace amount (Collins, 
1989; Bratt et al., 2003; Peterson and Dimberg, 2008); therefore, in this research, we focused on 
identifying and quantifying the three major avenanthramides from oat seeds of ten varieties and 
lines grown in Saskatoon, Saskatchewan, Canada. Phenolics were released from oat powder by 
treatment with 80% methanol to produce a phenolic-rich extract. The concentrated phenolic-rich 
extracts were then subjected to phenolic analysis using a reversed-phase HPLC-PDA method. The 
extraction and HPLC methods used in this research were adapted from those reported in literature, 
where phenolic separation and quantitation was obtained (Dimberg et al., 1993; Chu et al., 2013; 
Ishihara et al., 2014). Chemically synthesized Avn A, B and C were used as standards for both 
identification and quantitation in these phenolic-rich extracts. Based on chromatographic evidence, 
all ten oat extracts showed clear and sharp peaks that were identified as Avn A, B and C, which 
indicates these phenolics were effectively extracted and identified using the methods described. 
Concentrations of the identified Avn A, B and C in the ten phenolic-rich extracts were determined 
from linear calibration equations of Avn standards (concentration vs. peak area). Different oat 
varieties showed large concentration differences of the three avenanthramides (Table 4.1). The 
highest concentrations of individual and total Avn A, B and C were all found in BW10, followed 
by CDC Dancer and OT2021. Several studies have reported concentrations of the three 
avenanthramides from oat seeds grown in different countries. One study found that the 
concentration ranges of Avn A, B and C in three Swedish oat cultivars as 25-47 mg/kg, 21-43 
mg/kg and 21-43 mg/kg, respectively (Dimberg et al., 1996). Another study tested four oat 
cultivars in U.S.A and found that the average concentrations of Avn A, B and C were 54 mg/kg, 
36 mg/kg and 52 mg/kg, respectively (Emmons and Peterson, 1999). The difference between 
literature values and the values obtained in this study are most likely due to different genotype 
effects and environmental factors. Notably, Chu and colleagues identified and quantified Avn A, 
B and C from seven common Canadian oat varieties including CDC Dancer and CDC Morrison 
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(Chu et al., 2013), which were the same two varieties as we tested in this research. They found 
that CDC Dancer contained 5.06 mg/kg Avn A, 7.96 mg/kg Avn B and 7.15 mg/kg Avn C; CDC 
Morrison contained 1.05 mg/kg Avn A, 3.66 mg/kg Avn B and 3.70 mg/kg Avn C (Chu et al., 
2013). These values of the two oat varieties were around 2-4 times lower than the analytical results 
obtained in this study. It could be explained by the influence of environmental factors such as light, 
temperature and agronomic practices on oat cultivars. Furthermore, this indicates that Canadian 
grown cultivars are excellent candidates for extraction of avenanthramides for nutraceutical use. 
 
5.3 In vitro antioxidant activity of oat extracts and Avn A, B & C 
Several in vitro antioxidant activity assays are commonly used in research where the 
antioxidant potential of phenolic-rich extracts and pure compounds are determined, as they are 
relatively quick and convenient. The most commonly used methods are the ABTS and DPPH 
radical scavenging assays, ferric reducing ability of plasma (FRAP) assay, oxygen radical 
absorbance capacity and the inhibition of β-carotene bleaching (Prior et al., 2005).  In this study, 
we used the ABTS and DPPH in vitro methods to evaluate the antioxidant activity of oat extract 
samples and pure avenanthramides.  
Initially, the total phenolic contents of oat phenolic-rich extracts were determined by the 
Folin-Ciocalteu method. It was found that total phenolic content of the ten phenolic-rich extracts 
ranged from 78.5 ± 0.7 to 121.2 ± 2.5 mg GAE/100 g oat. The highest total phenolic content was 
found in BW10, followed by OT 2021 and BW5303. In literature, Chu and colleagues used the 
same method to determine total phenolic contents of seven oat varieties. They found that the range 
of total phenolic content was 57 to 94 mg GAE/100 g (Chu et al., 2013), which was lower than 
what was found in this study. In addition, total phenolic content of CDC Dancer and CDC Morrison 
were reported as 62 and 63 mg GAE/100 g in their study (Chu et al., 2013), which were also lower 
than the values we obtained. These differences in TPC values could be explained by the different 
extraction method used and/or chemical compound compositional differences impacted by 
environmental factors such as light, temperature and agronomic practices. Environmental factors 
are known to influence the expression of genes through modifying epigenetic profiles. Further 
analyses of these cultivars from these environmental conditions could identify the up-regulation 
of genes involved with the biosynthesis of Avns leading to increased levels. 
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Furthermore, ABTS and DPPH radical scavenging activities of the ten oat phenolic-rich 
extracts were measured. The highest ABTS radical scavenging activity was found for BW10, 
followed by OT2021 and CDC Dancer. The highest DPPH radical scavenging activity was found 
in OT2021, followed by BW10 and CDC Dancer. In literature, several studies have reported ABTS 
and DPPH radical scavenging activities of oat extracts arising from different parts of oat seeds (e.g. 
brans and hulls). The methods they used were unstandardized, which leads to the use of different 
reaction times, temperatures, reference standards and expressed units; therefore, it is difficult to 
compare our results to literature values. However, taken together the results from three different 
in vitro antioxidant assays used in this study, a consistent conclusion can be obtained, which is that 
oat phenolic-rich extracts from BW10 and OT2021 have the highest antioxidant activity among 
the ten oat varieties and lines. However, we found that CDC Dancer extract had the higher total 
concentrations of Avn A, B and C than OT2021 while OT2021 extract had the higher antioxidant 
than CDC Dancer. The reason might be that other phenolic compounds in oat extract also play 
critical roles in free radical scavenging and they may have synergistic effects. 
In addition to oat phenolic-rich extracts, the in vitro antioxidant activities of pure Avn A, 
B and C were also determined. It was observed that Avn C not only showed the highest ABTS and 
DPPH radical scavenging activities among the three avenanthramides, it was also higher than 
caffeic acid and Trolox, which are commonly considered as strong antioxidants. It could be 
explained by the differences in the number of phenol structure. Avn C has three phenol structures 
while Avn A, Avn B, Trolox and caffeic acid have less than two phenol structures. Similar results 
can be also found in literature. One study showed that Avn C had higher antioxidant activity than 
Avn A and Avn B using DPPH assay and β-carotene bleaching assay (Peterson et al., 2002). They 
also found that Avn C had more than twice DPPH radical scavenging activity than Trolox 
(Peterson et al., 2002). Another study used DPPH assay and ferric reducing ability of plasma 
(FRAP) assay to demonstrate that Avn C not only showed highest antioxidant activity among the 
three avenanthramides, it also had higher antioxidant activity than caffeic acid (Lee-Manion et al., 
2009). Taken together the results from our study and literature, we can see Avn C has strong 
antioxidant potential.  
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5.4 Protective effect of Avn C against cellular stress 
Although in vitro antioxidant activity results showed high antioxidant potential of Avn C, 
it is unclear if this compound can effectively pass through cells and exert cytoprotective effects. 
Therefore, we used normal human skin fibroblast cells (2DD cell line) to investigate the protective 
effect of Avn C against cellular stress including oxidative stress and inflammatory stress. In order 
to evaluate disease preventive potential instead of therapeutic potential of Avn C, 2DD cells were 
pre-treated with Avn C for 48 h and then stimuli were applied to induce cellular stress. Following 
treatment, several assays were employed to determine and confirm if Avn C had the ability to 
protect 2DD cells from induced cellular damage.  
Initially, the protective effects of Avn C against H2O2-induced oxidative stress were 
investigated. It has been proposed that cellular damage induced by oxidative stress is mostly 
associated with the production of H2O2, because it is more stable when compared with hydroxyl 
radicals or superoxide anions, and more capable of diffusing throughout a larger tissue area (Yuan 
et al., 2003; Ohshima, 2004). In order to evaluate oxidative stress levels inside cells, we used 
Mitotracker Orange dye to label free radicals inside cells. Mitotracker Orange is a non-fluorescent 
dye in its reduced form. When it interacts with free radicals, it is oxidized and shows orange 
fluorescence. By observing fluorescence intensity, we found that pre-treatment with Avn C 
reduced intracellular free radical levels induced by H2O2, thus indicating that Avn C was not only 
able to penetrate cells but also reduced intracellular free radical levels. It indicates that Avn C may 
directly neutralize free radicals inside cytoplasm before cellular components being damaged by 
free radicals. Furthermore, transcriptional levels of antioxidant enzymes were measured. 
Antioxidant enzymes are part of our endogenous antioxidant defense system and their expressions 
are usually stimulated by free radicals (Matés et al., 1999); therefore, they are also indicators of 
oxidative stress. We found that Avn C exposure lead to significant decreased levels of antioxidant 
enzyme transcripts induced by H2O2, which confirmed the intracellular antioxidant effect of Avn 
C.  
We then investigated the protective effects of Avn C against H2O2-induced inflammatory 
responses and DNA damage. Functional roles of H2O2 in inflammation have been investigated by 
several studies. Results have shown that H2O2 can act as a signaling molecule that activates 
inflammatory response through phosphorylation of tyrosine residues in NF-κB and its upstream 
regulators such as IκB and IKK (Schoonbroodt et al., 2000; Wittmann et al., 2012). In addition, 
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cellular damage caused by H2O2 releases TNF-α from damaged cells, resulting in the amplification 
of pro-inflammatory stimuli (Kim et al., 2008). In this study, it was observed that H2O2 induced 
the transcriptional expressions of Il-1β, Il-8, IL-6 and TNF-α, which were significantly reduced by 
Avn C pre-treatment. It was also found that H2O2 induced the expression of phosphorylated p65 
(p-p65), which is usually used as a marker for the activation of NF-κB and increased inflammatory 
response. Pre-treatment with Avn C significantly reduced the levels of p-p65 induced by H2O2. 
These observations indicated that Avn C has the ability to protect cells against free radical induced 
inflammatory responses. In addition to inflammation, DNA damage is another major effect of free 
radicals. Increased levels of DNA damage results from increased levels of free radicals and results 
in increase mutation rates, leading to cancer and a variety of age-related disorders (Wallace, 2002; 
Evans et al., 2004). Our results demonstrated that pre-treatment with Avn C significantly reduced 
H2O2-induced protein expression of p-H2AX, which is a sensitive marker for DNA double-strand 
breaks (Mah et al., 2010). Our observations demonstrate that Avn C has the ability to protect cells 
against free radical induced DNA damage, resulting in an increased DNA stability and function. 
This on its own, is a positive cytoprotection effect which would lead to increased cellular health. 
Given that Avn C was shown to have the ability to protect 2DD cells against oxidative 
stress-induced inflammatory response, further investigation was conducted to determine if Avn C 
can also protect cells from TNF-α induced inflammation. TNF-α was used instead of H2O2 to 
induce a pro-inflammatory response inside 2DD cells. TNF-α can either act as an autocrine or 
paracrine stimulator, binds cell receptors and trigger signaling events, leading to NF-𝜅B activation 
and pro-inflammatory cytokines expression (Liu and Han, 2001). Results from this study showed 
that TNF-α induced the transcriptional levels of Il-1β, Il-8 and TNF-α, which were significantly 
reduced by Avn C pre-treatment. Notably, only a slight increase in Il-6 transcripts was observed 
with TNF-α treatment, indicating that H2O2 and TNF-α have different impacts on pro-
inflammatory markers in primary skin fibroblasts. Pre-treatment with Avn C also showed a mild 
but significant decrease in the protein levels of p-p65 induced by TNF-α. These results suggest 
that Avn not only acts as radical scavenger for cellular protection, it can also function as a signaling 
mediator to regulate inflammatory response.  
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5.5 Impact of Avn C on gene regulation 
As Avn C was shown as an effective free radical scavenger that can protect cells against 
H2O2-induced and TNFα-induced cellular damage, including oxidative stress and inflammatory 
response, we further investigated if Avn C had an impact on gene expression that might attribute 
to its protective effects. We used the same cell line 2DD cells and treated them with either DMSO 
or AvnC for 48 h without any stress induction. 
As we observed anti-inflammatory effect of Avn C against H2O2-induced and TNF-α-
induced pro-inflammatory responses, we further investigated if Avn C could also reduce the basal 
level of inflammation through NF-κB inhibition. Several studies indicate that chronic low-grade 
inflammation is tightly associated with the aging process, including activation of the NF-κB 
system in various tissues (Spencer et al., 1997; Kim et al., 2002; Kim et al.,2006). It has also been 
shown that the expression of several inflammatory cytokines was increased during aging and they 
could be used as reliable aging parameters, including IL-6, TNF-α and IL-1β (Johnson, 2006; 
Salminen et al., 2008). Our results demonstrated that Avn C reduced basal inflammation through 
reduced pro-inflammatory cytokine transcripts, phosphorylated NF-κB expression and NF-κB 
DNA binding activity. The latter result was contradictory to a previous study that suggested that 
Avns do not directly inhibit the binding of NF-κB to DNA (Guo et al., 2008). However, we used 
a ChIP assay to directly show a decreased binding activity of NF-κB to DNA. These results 
demonstrate the suppression effect of Avn C on basal low-grade inflammation through NF-κB 
inhibition, indicating its potential as an anti-aging strategy.  
It has been found that many polyphenols (e.g. resveratrol and EGCG) influence cellular 
pathways that up-regulate antioxidant enzymes, which are involved in their antioxidant 
mechanisms (Khan et al., 1992; Lee et al., 1995; Khan et al., 2013). Experiments were conducted 
to evaluate if Avn C had a similar impact on antioxidant enzymes as resveratrol and EGCG. From 
the results, SOD1, CAT, GPx and GSS transcripts were not up-regulated by Avn C treatment; 
however, a significant increase in HO-1 expression was found. Cumulative evidence has shown 
that HO-1 is one of the most critical cytoprotective mechanisms due to its anti-oxidant, anti-
inflammatory and anti-apoptotic effects (Morse and Choi, 2005). HO-1 is a highly inducible form 
of heme oxygenase, which catabolizes heme to produce biliverdin, Fe2+, and CO (Maines, 1997). 
The expression of HO-1 is regulated by its transcription factor Nrf2. Under non-stress conditions, 
Nrf2 is sequestered in the cytoplasm by the actin-binding protein, Keap1. Following Keap1 
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degradation, Nrf2 is translocated from the cytosol to the nucleus to induce gene expression by 
binding to ARE and drive the expression of antioxidant enzymes (Itoh et al., 1999). In a previous 
study, Fu and colleagues found that Avn C induced HO-1 expression through increased Nrf2 
translocation in immortalized kidney epithelial cells (Fu et al., 2015). Here, we demonstrated that 
Avn C up-regulated HO-1 expression in normal human fibroblasts and further determined an 
increased Nrf2 DNA binding activity employing a ChIP assay. These results revealed that Avn C 
provides cytoprotection via mechanisms other than free radical scavenging and NF-B inhibition. 
Moreover, activation of Nrf2 in response to Avn C indicates a novel role for polyphenol in 
promoting cellular health and further indicates that Avn C could be used as a nutraceutical to 
promote increased healthy lifespan.  
As we observed a significantly decrease of proliferative rate with Avn C treated normal 
human fibroblast cells, we investigated if this effect was caused by activation of the autophagy 
pathway. Some promising polyphenols such as resveratrol and EGCG showed anti-proliferative 
and cytoprotective effects through activation of autophagy, which was mediated by SIRT1 
activation and mTOR inhibition (Park et al., 2016; Holczer et al.,2018). Autophagy is a regulated 
destructive mechanism of the cell that functions by protein degradation and turnover of the 
destroyed cell organelles for new cell formation (Morselli et al., 2009). This mechanism is one of 
the most critical strategies for cellular protection and strongly associated with healthy lifespan 
extension (Nakamura and Yoshimori, 2018). However, Avn C treated 2DD and FSF cells did not 
show changes in the expression of the autophagy marker protein LC3-II. Also, SIRT1 and 
phosphorylated mTOR, which are upstream molecules of autophagy activation and responsible for 
sensing cellular energy levels, did not show any changes either. These results indicate that Avn C 
reduces proliferative rate of normal human skin fibroblasts through autophagy-independent 
pathway. Although Avn C does not activate autophagy in human skin fibroblasts, it still shows the 
ability to slow down the growth rate of cells without causing cell death. Reduced growth rate 
represents reduced metabolic rate and reduced level of free radical generation, which might 
attribute to another possible mechanism of action for promoting cellular health. In addition to 
normal skin fibroblasts, Avn C also slowed down the growth rates of two cancer cell lines, which 
were MCF-7 (breast cancer cells) and U2OS (bone cancer cells). Although no significant cell death 
was found with AvnC-treated cancer cells, which shows that Avn C may be usable as adjunct 
treatments in combination with other chemotherapeutic agents such as taxol. 
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6. CONCLUSIONS 
The central hypothesis of this research is that Avn C not only has potential antioxidant 
activity, it can also activate signaling cascades that regulate gene expression involved in 
cytoprotection and regulates proliferative rates of normal human cells and cancer cells. To validate 
our hypothesis, Avn A, B and C from oat seeds of ten varieties and breeding lines were extracted, 
identified and quantified by HPLC-PDA method. Next, antioxidant activities of oat extracts and 
Avn A, B & C were evaluated employing ABTS and DPPH free radical scavenging systems. In 
addition, protective effects of Avn C against cellular damage induced by oxidative stress and 
inflammation were investigated. Furthermore, the impact of Avn C on gene regulation involved in 
inflammation and cryoprotection was also investigated. Finally, the impact of Avn C on the 
proliferation of human normal skin cells and cancer cells was determined. 
From results obtained from HPLC-PDA, it was found that different oat varieties showed 
large concentration differences of the three avenanthramides. The mean total amount of Avn A, B 
and C in the ten oat extracts ranged from 8.37 to 90.58 mg/kg oat. The concentrations of Avn A, 
B and C present in ten oat varieties and lines showed ranges of 1.76 to 21.39, 2.15 to 34.67 and 
4.43 to 34.52 mg/kg oat, respectively. Among ten oat varieties and lines, BW10 contained the 
highest amount of total and individual Avn A, B and C. Results from three different in vitro 
antioxidant assays used in this study demonstrated a consistent conclusion, which is that oat 
extracts from BW10 and OT2021 have the highest antioxidant activity among the ten oat varieties 
and lines. As for pure avenanthramides, Avn C not only showed the highest in vitro antioxidant 
activity among the three avenanthramides, it also showed higher in vitro antioxidant activity than 
caffeic acid and Trolox. 
Cytoprotective effect of Avn C against cellular stress was evaluated in normal human skin 
fibroblast (2DD cells). We found that Avn C was capable of penetrating into cells and scavenging 
intracellular free radicals induced by H2O2. In addition, pre-treatment with Avn C also protected 
cells from H2O2-induced antioxidant enzyme transcription, pro-inflammatory biomarker 
expressions and DNA double-strand breaks. Furthermore, pre-treatment with Avn C also reduced 
inflammatory responses induced by TNFα, indicating Avn C could function independently from 
its free radical scavenging ability and suppress inflammation.  
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Mechanistic studies revealed that Avn C suppressed basal level of pro-inflammatory 
transcripts and phosphorylated p65 through decreased NF-κB DNA binding activity. Moreover, 
Avn C induced HO-1 expression through increased Nrf2 DNA binding activity. Those results 
indicate that Avn C exerts antioxidant and anti-inflammatory effect through modulating NF-κB 
and HO-1/Nrf2 signaling pathways apart from free radical scavenging. In addition, Avn C slowed 
down the growth rate of normal human skin fibroblasts through autophagy-independent 
mechanisms. It also suppressed the growth of human breast cancer cells and bone cancer cells but 
did not induce cell death. 
In conclusion, Avn C protected cells from oxidative stress, DNA damage and inflammatory 
response. These cytoprotective effects were associated with its free radical scavenging activity, 
pro-inflammatory cytokine suppression, NF-κB inhibition, HO-1 induction and Nrf2 activation. 
Taken Together, Avn C exhibits multidirectional cytoprotective capabilities that contribute to an 
overall improvement of cellular health, suggesting its potential in disease prevention and 
promoting increased healthy lifespan. 
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7. FUTURE DIRECTIONS 
Results from this study illustrated cytoprotective mechanisms of Avn C including free 
radical scavenging, suppression of NF-κB and activation of HO-1/Nrf2 pathways. More 
mechanistic studies could be conducted. In order to find candidate targets, RNA-sequencing and 
ChIP-sequencing in normal human cells treated with Avn C can be performed to provide new 
insights on other possible and novel cellular pathways and molecular targets of Avn C. Moreover, 
results from this study showed that Avn C did not induce the expression of SIRT1, which is a 
major energy sensor inside cells and strongly associated with many cytoprotective pathways. 
However, it did not indicate if SIRT1 was activated or not. It is possible that although Avn C did 
not induce SIRT1 expression, but it activated SIRT1 function, which might lead to more cellular 
pathways influenced by Avn C. Further analyses such as knock out or knock down of SIRT1 could 
elucidate if Avn C has an impact on SIRT1 activation. In addition, Avn C slowed down the growth 
rates of 2DD fibroblasts, breast cancer cells and bone cancer cells, but no convincing evidence was 
found to explain the mechanisms of this anti-proliferative effect. Further studies could focus on 
the impact of Avn C on expression of proteins involved in cell cycle regulations such as cyclin-
dependent kinases (CDKs) and p53 pathways.  
As most polyphenols are not very stable and they are likely degraded in cell culture media 
after a period of time, further research could also be done to investigate half-life of Avn C and its 
depredated products in culture media. This would have implications on the potential half-life of 
these compounds in the blood stream. Furthermore, the evidence we obtained in this study was 
based on cell treatments using concentrations much higher than physiological concentrations. Also, 
limited evidence was found in literature providing bioavailability of Avn C in human. Phase I and 
II reactions in the liver clear compounds from the blood and reduce their bioavailability. Therefore, 
further studies using animal models and human trails could provide more evidence on 
bioavailability, toxicity, functional roles of Avn C and the fate of its bio-transformed metabolites 
in physiological systems.  
In summary, the future directions of this work could range from more mechanistic studies 
using cell culture models to the studies of functional roles of Avn C in physiological systems 
employing animal models and human trails. Those works taken together could provide convincing 
evidence on the effectiveness of Avn C in disease prevention and human health. 
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